Venous thromboembolism

I9_VTE

Phlebitis: Inflammation of a vein.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I26, I80, O87.1, O88.2 Hospital discharge: ICD-9 — 415\|451\|6713\|6714\|6732 Hospital discharge: ICD-8 — 450\|451\|671\|6739 Hospital discharge: excluded ICD-10 — I80.0# Hospital discharge: excluded ICD-9 — 4510 Cause of death: ICD-10 — I26, I80, O87.1, O88.2 Cause of death: ICD-9 — 415\|451\|6713\|6714\|6732 Cause of death: ICD-8 — 450\|451\|671\|6739 Cause of death: excluded ICD-10 — I80.0# Cause of death: excluded ICD-9 — 4510 2 out of 7 registries used, show all original rules.	27095
4. Check minimum number of events None	27095
5. Include endpoints None	27095
6. Filter based on genotype QC (FinnGen only)	27095

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF2

NAME	I9_VTE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I26\|I80\|O871\|O882
HD_ICD_9	415\|451\|6713\|6714\|6732
HD_ICD_8	450\|451\|671\|6739
HD_ICD_10_EXCL	I800
HD_ICD_9_EXCL	4510
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I26\|I80\|O871\|O882
COD_ICD_9	415\|451\|6713\|6714\|6732
COD_ICD_8	450\|451\|671\|6739
COD_ICD_10_EXCL	I800
COD_ICD_9_EXCL	4510
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Venous thromboembolism based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	248674	138776	106624
Only index persons	178972	102819	76153
Unadjusted period prevalence (%)
Whole population	3.54	3.97	2.98
Only index persons	3.41	3.78	2.91
Median age at first event (years)
Whole population	65.14	66.44	63.36
Only index persons	62.36	63.33	61.06

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	27095	14521	12574
Unadjusted period prevalence (%)	5.23	4.95	5.54
Median age at first event (years)	60.38	58.17	62.92

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
24178: Matched controls
235435

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

8.0

323.0

4758

7003

K93

ICPC

Pulmonary embolism

82.0

323.0

1124

140

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

7.2

323.0

1951

2829

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

323.0

6746

38062

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

89.8

323.0

1657

193

R06.0

ICD-10 Finland

Dyspnoea

2.5

323.0

7632

36691

N02AA05

ATC

oxycodone; systemic

2.4

323.0

4434

20279

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

14.5

323.0

1227

864

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

7.6

323.0

6759

11441

D68.8

ICD-10 Finland

Other specified coagulation defects

17.2

323.0

662

385

B01AB10

ATC

tinzaparin; parenteral

4.4

323.0

2909

7066

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

130.0

323.0

2801

237

4511A

ICD-9 Finland

Phlebitis and thrombophlebitis, Of deep vessels of lower extremities

+∞

323.0

1240

45100

ICD-8 Finland

Phlebitis and thrombophlebitis, Of lower extremities

+∞

323.0

1030

R60.0

ICD-10 Finland

Localized oedema

2.6

323.0

3333

13855

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

14.2

323.0

1294

931

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

97.4

323.0

5561

720

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

126.6

323.0

1927

161

M79.6

ICD-10 Finland

Pain in limb

2.1

323.0

9171

53801

B01AF02

ATC

apixaban; oral

3.1

323.0

3537

12200

B01AB04

ATC

dalteparin; parenteral

5.0

323.0

2263

4785

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1378.4

323.0

9819

116

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

323.0

11628

73703

K94

ICPC

Phlebitis/thrombophlebitis

15.8

323.0

1109

713

I26

ICD-10 Finland

Pulmonary embolism

87.5

323.0

1024

119

4151A

ICD-9 Finland

Acute pulmonary heart disease, Pulmonary embolism and infarction

+∞

323.0

442

B01AF01

ATC

rivaroxaban; oral

3.1

323.0

4218

15120

N02AX02

ATC

tramadol; systemic, rectal

1.8

323.0

10468

71219

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

997.8

323.0

2893

C03CA01

ATC

furosemide; systemic

2.0

323.0

8615

50439

B01AB05

ATC

enoxaparin; parenteral

4.6

323.0

12568

44970

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

32.5

323.0

688

212

I80.20

ICD-10 Finland

Phlebitis and thrombophlebitis in the iliac vein

418.9

323.0

591

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

323.0

4012

16337

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

118.2

323.0

4691

479

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

186.1

323.0

1919

109

B01AA03

ATC

warfarin; systemic

6.3

323.0

11468

29476

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

313.0

5268

29434

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.5

311.1

2808

11867

A02BC02

ATC

pantoprazole; systemic

1.7

309.8

15262

118839

A46

ICD-10 Finland

Erysipelas

2.2

307.7

3828

18896

JN4BD

NOMESCO Finland

Extensive body CT

2.3

296.0

3103

14129

I80

ICD-10 Finland

Phlebitis and thrombophlebitis

10.2

295.7

610

594

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

294.6

4102

21206

H02AB02

ATC

dexamethasone; systemic

2.4

292.3

2830

12380

H02AB06

ATC

prednisolone; systemic

1.7

292.1

11083

79698

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

288.5

3082

14149

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

288.2

5236

29952

N02BE01

ATC

paracetamol; systemic, rectal

1.8

283.7

20102

171538

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

250.6

4173

22967

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

243.4

4287

24048

J01MA12

ATC

levofloxacin; systemic

1.8

242.8

4665

26977

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.3

236.9

1303

4005

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

226.7

4423

25633

J01DB01

ATC

cefalexin; oral

1.6

226.4

18408

155764

R50.9

ICD-10 Finland

Fever, unspecified

2.0

226.0

3343

17516

130

Kela drug reimbursment

Malignant tumour

2.3

225.1

2283

10138

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

6.4

224.9

623

966

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

220.1

2305

10392

R4110

NOMESCO Finland

Physiotherapy

1.7

213.3

6129

39877

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

209.9

7961

55680

ZXD05

NOMESCO Finland

Urgent procedure

1.6

207.2

7058

47994

GD2SN

NOMESCO Finland

Lung ventilation SPECT

12.1

202.4

382

311

I87.0

ICD-10 Finland

Postthrombotic syndrome

39.6

200.7

258

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

198.8

6702

45343

Z51.5

ICD-10 Finland

Palliative care

2.5

196.5

1688

6860

N03AX16

ATC

pregabalin; oral

1.7

196.0

5384

34443

GD1UN

NOMESCO Finland

Lung circulation SPECT

12.7

189.1

349

271

I80.2

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

+∞

188.9

183

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

186.3

2642

13535

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

184.3

9971

75060

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

182.9

7509

53081

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

182.4

6910

47904

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

179.2

6176

41788

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

176.6

4969

31854

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

175.9

7557

53866

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

175.9

3168

17702

ZX120

NOMESCO Finland

Intravenous

2.1

173.8

2299

11430

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

173.3

3977

24017

JN4AD

NOMESCO Finland

Body CT examination

2.2

171.3

1928

8935

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

171.0

5881

39684

45001

ICD-8 Finland

Pulmonary embolism and infarction, Embolia

+∞

170.3

165

AA1AD

NOMESCO Finland

CT of head and brain

1.6

169.9

5568

37104

J01FF01

ATC

clindamycin; systemic

1.6

168.8

5927

40176

A04AA01

ATC

ondansetron; systemic, rectal

2.3

166.8

1629

7057

R03AC02

ATC

salbutamol; inhalant

1.5

166.1

11108

86701

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

165.5

8111

59327

A04AA02

ATC

granisetron; systemic, transdermal

2.4

160.0

1502

6374

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.4

159.3

833

2453

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

159.1

2477

13100

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

157.7

3941

24329

Z3226

NOMESCO Finland

Physiotherapist

1.7

157.7

4164

26115

L28

ICPC

Limited function/disability (L)

1.7

157.1

3725

22641

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

155.4

3657

22177

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.8

154.7

1043

3667

J01MA02

ATC

ciprofloxacin; systemic

1.5

154.6

8764

65828

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

153.1

3505

21067

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.3

152.0

1469

6320

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

151.2

1829

8729

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.6

146.2

1167

4536

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

145.6

3034

17688

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

145.2

3217

19116

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

143.4

3239

19356

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

140.8

3861

24379

Z3231

NOMESCO Finland

Registered nurse

1.5

139.9

5986

42137

A28

ICPC

Limited function/disability NOS

1.7

139.5

3602

22359

L17

ICPC

Foot/toe symptom/complaint

1.5

137.7

5312

36503

SPAT1254

SPAT

Administration of medicine

1.7

134.9

3296

20121

UJF32

NOMESCO Finland

Coloscopy

1.5

134.3

5715

40111

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.4

133.9

687

1992

WX892

NOMESCO Finland

Monitored bed care

2.0

133.3

1797

8956

L14

ICPC

Leg/thigh symptom/complaint

2.1

132.9

1698

8278

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

132.9

6760

49263

R53

ICD-10 Finland

Malaise and fatigue

1.6

132.7

4475

29747

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

131.7

3783

24133

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

130.0

1183

4928

R02

ICPC

Shortness of breath/dyspnoea

1.8

130.0

2649

15295

A06AD11

ATC

lactulose; oral

1.6

127.0

3484

21928

M04AA01

ATC

allopurinol; systemic

1.7

126.3

3076

18730

ZXE00

NOMESCO Finland

One hour or less

1.4

125.5

8367

64078

J01DA01

ATC

[U] cefalexin; systemic

1.4

123.7

13639

113933

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

123.4

1527

7338

J01MA14

ATC

moxifloxacin; systemic

1.9

123.2

2005

10722

K99

ICPC

Cardiovascular disease other

2.9

120.3

765

2584

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

2.7

119.9

856

3110

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

119.8

1922

10219

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

119.5

3310

20855

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

119.5

6486

47655

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

117.7

2303

13101

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

116.5

2089

11541

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

115.8

2288

13052

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

114.4

1102

4718

L01BC06

ATC

capecitabine; oral

2.6

114.3

879

3336

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

111.1

10097

81049

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

109.8

3017

18929

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.8

109.6

2157

12276

SPAT1229

SPAT

Assessment of need for aid

1.8

108.4

1884

10289

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

107.7

1815

9804

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.6

106.4

813

3075

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

106.3

2987

18840

S97

ICPC

Chronic ulcer skin

2.1

106.3

1284

6097

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

105.1

1257

5941

Z2446

NOMESCO Finland

Social worker

2.0

104.3

1360

6666

SPAT1263

SPAT

Sampling

1.4

101.6

8758

69356

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.1

101.5

584

1842

R03BB04

ATC

tiotropium bromide; inhalant

1.7

100.9

2297

13652

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

3.2

100.3

566

1761

H02AB07

ATC

prednisone; oral

1.6

99.4

3093

19995

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

98.7

4488

31605

GD1AD

NOMESCO Finland

Thorax CT examination

2.3

98.5

992

4334

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.8

98.0

688

2472

C07AB07

ATC

bisoprolol; oral

1.3

97.0

10581

86716

WZC30

NOMESCO Finland

Teaching

1.6

96.8

2702

16980

C03DA01

ATC

spironolactone; oral

1.7

96.5

2415

14733

PHD99

NOMESCO Finland

Resection of other vein

2.0

96.4

1372

6956

N05CF01

ATC

zopiclone; oral

1.4

96.4

7066

54346

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

95.4

952

4141

WW500

NOMESCO Finland

Blood transfusion

2.3

94.4

921

3963

S18

ICPC

Laceration/cut

1.3

94.0

8715

69544

B01AX05

ATC

fondaparinux; parenteral

5.1

93.9

311

601

N03AX12

ATC

gabapentin; oral

1.6

92.9

3125

20558

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

92.6

1082

5059

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.0

92.5

1337

6818

J01FA06

ATC

roxithromycin; oral

1.3

92.3

8375

66559

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

92.2

1997

11675

A02BC01

ATC

omeprazole; systemic

1.4

91.9

5942

44644

A08

ICPC

Swelling

2.2

91.5

965

4307

WX002

NOMESCO Finland

Sedation and analgesia

1.5

91.4

4152

29178

A02BC05

ATC

esomeprazole; systemic

1.3

90.9

8373

66651

Z2221

NOMESCO Finland

Medical doctor

1.4

90.7

5651

42166

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

89.3

2115

12686

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

4.3

89.3

347

792

67100

ICD-8 Finland

Puerperal phlebitis and thrombosis, Thrombophlebitis extremitatis inferioris

+∞

88.7

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

88.6

8090

64235

E66.8

ICD-10 Finland

Other obesity

2.2

88.5

977

4453

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

88.5

2417

15076

H02AB04

ATC

methylprednisolone; systemic

1.5

88.0

3009

19845

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

87.6

1619

8998

ZXA00

NOMESCO Finland

Right side

1.4

87.3

5835

44016

PH7FT

NOMESCO Finland

Inmplantation of filter to inferior vena cava with radiological guidance

151.5

87.1

R11

ICD-10 Finland

Nausea and vomiting

1.8

87.0

1622

9041

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

86.7

4022

28345

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

7.4

86.3

214

285

ZXA05

NOMESCO Finland

Left side

1.4

86.2

5462

40808

SPAT1255

SPAT

Intravenous administration of medicine

1.9

85.4

1421

7621

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

2.9

84.5

557

1926

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

84.2

3964

27995

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

2.5

84.1

714

2861

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

83.8

1371

7308

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.0

83.7

1104

5427

L03AA13

ATC

pegfilgrastim; parenteral

2.3

83.6

822

3550

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

7.5

83.3

204

267

M54.5

ICD-10 Finland

Low back pain

1.4

83.1

6273

48208

R52.9

ICD-10 Finland

Pain, unspecified

1.8

82.8

1668

9523

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

82.8

3220

21846

A41.9

ICD-10 Finland

Sepsis, unspecified

2.3

82.1

833

3650

N05BA04

ATC

oxazepam; oral

1.4

82.0

4991

36964

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.0

82.0

1063

5189

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.0

81.5

1111

5532

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

80.9

1213

6262

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

80.8

3428

23677

M10.9

ICD-10 Finland

Gout, unspecified

1.8

80.8

1407

7660

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

80.7

1339

7170

N30.0

ICD-10 Finland

Acute cystitis

1.5

80.6

2748

18085

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

79.9

2831

18791

G47.3

ICD-10 Finland

Sleep apnoea

1.4

79.8

4018

28716

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.7

79.5

583

2152

JN4CD

NOMESCO Finland

Very extensive body CT

2.2

79.1

897

4136

J96.1

ICD-10 Finland

Chronic respiratory failure

2.7

77.3

544

1957

J01AA02

ATC

doxycycline; systemic

1.3

77.0

16997

151470

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

76.8

1576

9042

R51.80

ICD-10 Finland

Headache

1.5

76.7

2561

16757

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

76.6

818

3671

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.7

76.5

350

926

P01AB01

ATC

metronidazole; oral, rectal

1.3

76.2

7719

61856

N06AX11

ATC

mirtazapine; oral

1.3

75.9

6231

48381

L03AA02

ATC

filgrastim; parenteral

2.5

75.2

608

2371

O22.3

ICD-10 Finland

Deep phlebothrombosis in pregnancy

32.6

75.0

100

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

74.9

1246

6674

D68.2

ICD-10 Finland

Hereditary deficiency of other clotting factors

14.8

74.2

127

I82

ICD-10 Finland

Other venous embolism and thrombosis

13.2

73.4

132

L04AA06

ATC

mycophenolic acid; systemic

3.3

73.4

397

1199

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

73.4

1477

8422

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

73.4

610

2415

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

73.1

2004

12475

I50.0

ICD-10 Finland

Congestive heart failure

1.7

73.0

1695

10087

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

72.8

1437

8143

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

71.5

3028

20857

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

71.4

1216

6564

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

71.2

1415

8033

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.0

70.8

932

4574

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

70.6

12800

110421

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

70.5

2173

13928

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

70.5

1205

6513

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.1

69.9

858

4092

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

69.8

1049

5417

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.8

69.6

1283

7111

X58

ICD-10 Finland

Exposure to other specified factors

1.5

69.6

2450

16204

E0000UV

ATC

1.3

69.4

7616

61502

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

69.4

3644

26167

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

69.4

1483

8611

N06AB04

ATC

citalopram; systemic

1.4

69.3

4224

31160

K07

ICPC

Swollen ankles/oedema

2.0

68.8

944

4708

128

Kela drug reimbursment

Cancers of female genital organs

3.1

68.7

397

1258

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

68.6

1482

8632

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.3

68.4

658

2809

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

68.0

784

3641

L04AX01

ATC

azathioprine; systemic

2.1

67.9

839

4011

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.4

67.8

593

2412

N05BA01

ATC

diazepam; systemic, rectal

1.5

67.3

2685

18247

127

Kela drug reimbursment

Transplant complication

3.4

67.1

345

1004

45199

ICD-8 Finland

Phlebitis and thrombophlebitis, Of other and unspecified sites

+∞

67.0

L15

ICPC

Knee symptom/complaint

1.4

67.0

3934

28808

WX110

NOMESCO Finland

Local anesthesy

1.3

66.9

13555

118160

4538X

ICD-9 Finland

Other venous embolism and thrombosis, Of other specified veins

10.0

66.7

137

134

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

66.4

1352

7730

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.1

66.4

391

1256

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

66.2

2030

12990

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

65.9

1168

6388

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

65.8

3490

25081

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

65.7

884

4372

WX402

NOMESCO Finland

General anaesthesia

1.5

65.4

2963

20661

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

65.3

4141

30711

A04AA55

ATC

palonosetron, combinations; systemic

2.4

65.2

585

2411

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

65.1

7586

61616

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

65.0

3582

25920

R07.3

ICD-10 Finland

Other chest pain

1.6

64.9

1833

11488

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.1

64.7

769

3618

M25.5

ICD-10 Finland

Pain in joint

1.3

64.3

5172

39840

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

64.1

7212

58271

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

63.9

749

3502

R42

ICD-10 Finland

Dizziness and giddiness

1.4

63.8

4438

33407

D68.9

ICD-10 Finland

Coagulation defect, unspecified

8.4

63.5

144

168

K78

ICPC

Atrial fibrillation/flutter

1.6

63.5

1680

10349

J01EA01

ATC

trimethoprim; systemic

1.3

63.4

5056

38880

UKC02

NOMESCO Finland

Cystoscopy

1.4

63.2

3398

24465

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

62.6

2158

14184

J01CA08

ATC

pivmecillinam; oral

1.3

62.6

7431

60428

A06AH03

ATC

naloxegol; oral

3.7

62.5

287

763

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.1

62.1

356

1122

N05AH04

ATC

quetiapine; oral

1.4

62.0

2815

19618

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

10.6

61.7

123

114

I82.80

ICD-10 Finland

Emboli and thrombosis in the subclavian vein

14.9

61.7

105

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

61.3

1026

5502

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

61.0

2278

15240

SPAT1301

SPAT

No procedures

1.3

60.9

6364

50830

R03BA05

ATC

fluticasone; inhalant

1.4

60.2

3340

24164

Z71.8

ICD-10 Finland

Other specified counselling

1.4

60.0

4218

31764

WX882

NOMESCO Finland

High dependency care

2.3

59.6

575

2460

R03DC03

ATC

montelukast; oral

1.4

59.6

2800

19637

J01CA04

ATC

amoxicillin; systemic

1.3

59.4

16647

149701

R03BA02

ATC

budesonide; inhalant

1.4

59.0

3274

23678

SPAT1262

SPAT

Handing over of treatment supplies

1.4

58.9

3656

26960

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

58.9

1368

8127

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

58.9

4836

37288

45499

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

1.7

58.8

1419

8519

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

58.8

1003

5413

C02KX05

ATC

riociguat; oral

+∞

58.8

M05BX04

ATC

denosumab; parenteral

1.8

58.7

1020

5538

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

58.2

7762

63898

E66.9

ICD-10 Finland

Obesity, unspecified

2.2

58.2

613

2735

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

2.8

58.1

392

1377

TGC00

NOMESCO Finland

Bronchial lavation

2.3

57.8

549

2330

N06AX16

ATC

venlafaxine; oral

1.5

57.8

2274

15373

Z86.7

ICD-10 Finland

Personal history of diseases of the circulatory system

38.1

57.7

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1.9

57.6

876

4541

J46

ICD-10 Finland

Status asthmaticus

2.3

57.2

564

2438

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

57.2

676

3170

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

57.2

892

4664

R55

ICD-10 Finland

Syncope and collapse

1.5

57.1

2196

14769

W19

ICD-10 Finland

Unspecified fall

1.6

56.7

1807

11649

L16

ICPC

Ankle symptom/complaint

1.6

56.5

1745

11165

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.0

56.2

721

3498

WX320

NOMESCO Finland

Spinalanesthesy

1.3

56.0

4451

34116

SPAT1211

SPAT

Application of soft bandage

1.6

55.9

1728

11059

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

55.8

2518

17500

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.5

55.7

2085

13939

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

55.7

7649

63099

R03AC03

ATC

terbutaline; inhalant

1.4

55.6

2575

17984

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

55.6

1317

7863

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

55.0

1497

9278

PH2ST

NOMESCO Finland

Endovascular thrombolysis of pelvic and lower leg veins with radiological guidance

535.0

55.0

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

55.0

2103

14123

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

54.8

1293

7712

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

54.7

4064

30815

4512A

ICD-9 Finland

Phlebitis and thrombophlebitis, Of lower extremities, unspecified

+∞

54.7

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

54.6

3394

25002

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

54.6

1103

6284

SPAT1216

SPAT

Assessment of functional ability

1.4

54.4

3134

22784

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

54.2

1084

6155

PH2AE

SPAT

3.7

54.2

251

674

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

54.0

891

4750

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

53.8

1729

11162

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.1

53.3

613

2844

R4190

NOMESCO Finland

Nutritional therapy

2.2

53.2

583

2647

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

53.1

961

5289

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

53.1

1490

9308

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

2.7

53.1

382

1397

TK800

NOMESCO Finland

Hemodialysis

2.4

52.8

456

1846

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

52.7

5648

45082

A02BC03

ATC

lansoprazole; oral

1.3

52.5

5940

47740

M01AX17

ATC

nimesulide; oral

1.3

52.5

4971

39018

N06AA09

ATC

amitriptyline; systemic

1.5

52.1

1959

13099

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

52.1

2106

14306

XG466

NOMESCO Finland

Sleep oxymetry

2.0

51.7

659

3191

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

3.7

51.6

235

622

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.2

51.4

541

2411

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

51.2

1253

7547

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

51.0

1343

8250

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

7.2

50.8

126

170

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

50.5

878

4767

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

50.4

4961

39107

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.8

50.4

940

5222

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.3

50.4

482

2055

R06AE07

ATC

cetirizine; oral

1.2

50.4

8034

67234

A07AA02

ATC

nystatin; oral

1.6

50.3

1253

7580

N05CD07

ATC

temazepam; oral

1.4

50.2

2681

19207

XG410

NOMESCO Finland

Flow-volume spirometry

1.9

50.0

803

4242

R52.0

ICD-10 Finland

Acute pain

2.2

49.9

559

2562

M01AH02

ATC

rofecoxib; oral

1.4

49.8

2650

18971

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

49.7

2131

14644

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

49.3

1458

9220

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

49.3

1803

11982

45309

ICD-8 Finland

Other venous embolism and thrombosis, NUD (cerebri, cordis, mesenterii, pulmonis exceptis)

8.4

49.3

111

129

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

48.9

973

5514

A01

ICPC

Pain general/multiple sites

1.6

48.6

1416

8923

R04.2

ICD-10 Finland

Haemoptysis

1.9

48.5

694

3514

45198

ICD-8 Finland

Phlebitis and thrombophlebitis, Alia definita

+∞

48.5

A04

ICPC

Weakness/tiredness general

1.4

48.4

2385

16828

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.4

48.3

243

698

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.2

48.3

502

2226

WW200

NOMESCO Finland

Immunization

2.2

48.1

516

2320

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

2.0

48.1

626

3055

PHD76

NOMESCO Finland

Resection of long saphenous vein

1.8

47.8

920

5164

HA1AA

NOMESCO Finland

X-ray mammography

1.6

47.5

1313

8163

PH7YT

NOMESCO Finland

Dilatation of inferior vena cava or lower extremity vein with stent

75.4

47.3

M79.1

ICD-10 Finland

Myalgia

1.4

47.2

2161

15030

N18.8

ICD-10 Finland

Other chronic renal failure

2.1

46.9

583

2794

S06.0

ICD-10 Finland

Concussion

1.5

46.6

1819

12249

ZXA10

NOMESCO Finland

Bilateral

1.3

46.6

3630

27641

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

46.6

1891

12842

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

46.4

1400

8892

M02AA07

ATC

piroxicam; topical

1.2

46.3

7456

62299

N05BA06

ATC

lorazepam; systemic, sublingual

1.7

46.3

999

5803

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.3

46.2

454

1962

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.9

45.6

715

3747

WF004

NOMESCO Finland

Palliative radiotherapy

2.4

45.5

411

1704

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.7

45.3

955

5507

C08CA01

ATC

amlodipine; oral

1.2

45.2

7378

61696

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

45.1

979

5698

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

7.6

45.0

108

139

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

45.0

3962

30690

A11CC03

ATC

alfacalcidol; systemic

2.2

45.0

466

2063

RS221

NOMESCO Finland

2.8

44.9

299

1045

M05BA04

ATC

alendronic acid; oral

1.5

44.9

1674

11164

WX872

NOMESCO Finland

Intensive care

1.7

44.6

950

5495

4549X

ICD-9 Finland

Varicose veins of lower extremities, Without mention of ulcer or inflammation

1.7

44.6

1048

6239

Z94.0

ICD-10 Finland

Kidney transplant status

3.3

44.5

235

701

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.2

44.4

238

718

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

2.6

44.4

337

1274

JAH00

NOMESCO Finland

Laparotomy

2.1

44.1

545

2607

A04AD12

ATC

aprepitant; systemic

2.4

44.1

396

1635

M03BX02

ATC

tizanidine; oral

1.2

44.0

11844

104188

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

43.8

1878

12887

WX725

NOMESCO Finland

Noninvasive ventilation

1.8

43.8

822

4575

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.8

43.7

299

1060

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.4

43.6

390

1610

N05AA02

ATC

levomepromazine; systemic

1.8

43.5

763

4154

R05FB02

ATC

cough suppressants and expectorants

1.2

43.5

7674

64649

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

43.5

1855

12719

PH7ZT

NOMESCO Finland

Intravenous removal of filter to inferior vena cava

219.4

43.5

J96.0

ICD-10 Finland

Acute respiratory failure

2.8

43.4

294

1037

J45

ICD-10 Finland

Asthma

1.5

43.4

1655

11087

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1.9

43.2

657

3404

WX722

NOMESCO Finland

PEEP

1.7

43.1

889

5094

I27.0

ICD-10 Finland

Primary pulmonary hypertension

8.4

43.1

113

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.0

43.1

598

2994

R31

ICD-10 Finland

Unspecified haematuria

1.4

43.0

1964

13645

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

42.9

1721

11650

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.9

42.6

642

3316

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

42.5

1675

11293

A02BA02

ATC

ranitidine; systemic

1.3

42.5

3996

31206

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.2

42.5

466

2118

XW000

NOMESCO Finland

Bone marrow biopsy

1.8

42.5

774

4268

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

4.6

42.5

151

319

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

1.8

42.3

714

3835

S80.0

ICD-10 Finland

Contusion of knee

1.6

42.3

1058

6406

FBB20

NOMESCO Finland

Thrombendarterectomy of pulmonary artery in chronic obstruction

+∞

42.3

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.3

42.2

420

1825

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

42.2

4883

39168

R4120

NOMESCO Finland

Occupational therapy

1.6

42.0

1121

6901

J94.8

ICD-10 Finland

Other specified pleural conditions

2.4

42.0

359

1448

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.1

41.9

496

2332

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.9

41.8

625

3218

T82

ICPC

Obesity

2.0

41.7

566

2809

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.5

41.6

330

1279

M48.0

ICD-10 Finland

Spinal stenosis

1.4

41.3

2363

17100

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

41.2

13466

120317

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

41.2

3478

26744

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

41.2

2465

17976

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.3

41.1

388

1646

B03XA02

ATC

darbepoetin alfa; parenteral

2.3

40.9

381

1606

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

40.9

1439

9468

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

40.9

999

6009

N03AX09

ATC

lamotrigine; oral

1.8

40.6

673

3596

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

40.5

2166

15486

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

40.5

852

4909

K92.1

ICD-10 Finland

Melaena

1.6

40.2

1014

6153

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

40.2

4833

38911

PHM77

NOMESCO Finland

Endovenous obliteration of v.saphena parva

3.2

40.0

216

657

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

39.9

1144

7172

A07AA09

ATC

vancomycin; oral

2.7

39.7

279

1007

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

39.6

1494

9976

J01CE08

ATC

benzathine benzylpenicillin; parenteral

2.9

39.5

243

808

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

3.2

39.5

214

652

K29

ICPC

Cardiovascular sympt/complt other

1.7

39.4

812

4655

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.0

39.2

516

2533

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.6

39.1

1096

6837

R03DA04

ATC

theophylline; systemic, rectal

1.6

39.0

1114

6979

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

39.0

3409

26327

E86

ICD-10 Finland

Volume depletion

2.0

39.0

487

2340

N06AX21

ATC

duloxetine; oral

1.4

38.9

1767

12251

A29

ICPC

General symptom/complaint other

1.4

38.8

2024

14398

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

38.8

647

3463

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.2

38.7

396

1745

R03AC13

ATC

formoterol; inhalant

1.7

38.7

916

5465

H02AB09

ATC

hydrocortisone; systemic

2.2

38.6

403

1791

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.7

38.6

282

1043

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.2

38.6

426

1944

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.2

38.4

402

1791

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

2.6

38.4

284

1058

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

38.4

2624

19538

J01FA10

ATC

azithromycin; systemic

1.2

38.4

10532

92309

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

38.2

2462

18162

SPAT1260

SPAT

Consultation of another employee

1.3

38.1

3282

25277

G44.2

ICD-10 Finland

Tension-type headache

1.4

38.1

2140

15425

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

38.0

1222

7878

PH9AT

NOMESCO Finland

Expansion (PTA) of vein not elsewhere classified

70.0

37.4

M01AE02

ATC

naproxen; oral, rectal

1.2

37.4

10802

95028

ZX108

NOMESCO Finland

Inhalation

3.6

37.4

173

467

J45.8

ICD-10 Finland

Mixed asthma

1.9

37.2

549

2815

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

37.2

4824

39132

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.1

37.1

425

1970

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

37.1

1543

10513

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.2

37.0

371

1619

N19

ICD-10 Finland

Unspecified kidney failure

1.8

37.0

656

3584

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

36.9

1173

7538

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.2

36.7

4944

40269

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.0

36.7

488

2406

R18

ICD-10 Finland

Ascites

2.3

36.6

358

1547

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.6

36.6

891

5354

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.9

36.5

579

3049

B01AE07

ATC

dabigatran etexilate; oral

1.7

36.4

763

4393

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.6

36.4

1007

6258

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

36.3

2030

14616

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

36.3

529

2699

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.6

36.2

282

1084

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

3.6

36.1

171

471

L04AD01

ATC

ciclosporin; systemic

2.3

36.1

331

1384

4518X

ICD-9 Finland

Phlebitis and thrombophlebitis, Of other sites

+∞

36.1

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.5

35.9

1313

8711

R05

ICD-10 Finland

Cough

1.3

35.9

3433

26807

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.0

35.8

452

2181

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.7

35.6

774

4506

M01AX05

ATC

glucosamine; oral

1.3

35.5

4014

32007

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.7

35.5

839

5002

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.4

35.5

177

508

SPAT1234

SPAT

Support of social functional capacity

1.6

35.4

969

6006

N05AH03

ATC

olanzapine; systemic

1.6

35.3

893

5418

O22.8

ICD-10 Finland

Other venous complications in pregnancy

95.1

35.3

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

35.3

960

5942

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.2

35.3

190

578

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.8

35.2

599

3232

S22.3

ICD-10 Finland

Fracture of rib

1.5

35.2

1153

7463

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.8

35.1

621

3390

A12BA01

ATC

potassium chloride; oral

1.6

35.1

985

6145

A12AA04

ATC

calcium carbonate; oral

2.4

35.0

318

1324

A41.8

ICD-10 Finland

Other specified sepsis

2.3

34.9

334

1427

L03

ICPC

Low back symptom/complaint

1.3

34.8

4173

33501

GAE40

NOMESCO Finland

Operation on rib and soft tissues for thoracic outlet syndrome

9.4

34.8

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.0

34.8

447

2176

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.9

34.8

517

2661

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

34.8

3013

23203

R52.2

ICD-10 Finland

Other chronic pain

1.8

34.5

570

3043

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

34.5

1074

6868

PH2BC

NOMESCO Finland

Extensive flebography of lower extremity with X-ray

26.0

34.4

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.9

34.3

490

2484

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

34.1

817

4887

N06AB10

ATC

escitalopram; oral

1.3

34.0

3125

24251

M01AB05

ATC

diclofenac; systemic, rectal

1.2

33.8

13298

119724

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

33.7

678

3857

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

33.7

1997

14510

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

33.7

1373

9312

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.7

33.7

231

824

ZY010

NOMESCO Finland

Hospital outpatient

1.7

33.6

662

3740

R04.0

ICD-10 Finland

Epistaxis

1.5

33.6

1346

9097

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.8

33.6

147

380

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.7

33.6

725

4214

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

33.5

4129

33241

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.4

33.4

285

1151

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

1.7

33.4

694

3984

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

2.8

33.4

225

794

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

2.5

33.4

278

1109

SPAT1240

SPAT

Therapeutic discussion

1.4

33.4

1460

10045

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

33.1

2098

15412

PH2AC

NOMESCO Finland

Flebography of lower extremity with X-ray

12.5

33.1

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

2.9

33.0

205

688

FB1ST

NOMESCO Finland

Catheter-based therapy of pulmonary embolism

+∞

33.0

S29

ICPC

Skin symptom/complaint other

1.3

32.9

2936

22683

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.9

32.9

487

2501

E66

ICD-10 Finland

Obesity

1.8

32.9

627

3510

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

1.9

32.8

531

2816

S76

ICPC

Skin infection other

1.6

32.8

870

5349

N03AE01

ATC

clonazepam; systemic

1.6

32.7

1004

6398

J01MA06

ATC

norfloxacin; oral

1.3

32.7

2514

19019

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

32.7

1108

7226

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

32.7

1566

10960

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

3.0

32.6

197

650

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.2

32.6

174

527

I82.21

ICD-10 Finland

Emboli and thrombosis in the inferior vena cava

16.9

32.5

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

2.1

32.3

366

1692

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

32.3

4907

40413

P01BA02

ATC

hydroxychloroquine; oral

1.4

32.2

1404

9649

R06.2

ICD-10 Finland

Wheezing

1.7

32.2

712

4167

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

2.7

32.1

223

803

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

32.1

4623

37852

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

32.0

2078

15321

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

3.3

32.0

165

487

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.1

32.0

377

1770

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.1

31.9

358

1646

R96

ICPC

Asthma

1.4

31.9

1461

10140

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.5

31.8

1152

7622

NF3AA

NOMESCO Finland

Femur X-ray examination

2.1

31.8

369

1722

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

31.7

1395

9604

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.5

31.7

992

6350

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

2.5

31.7

254

993

J01FA09

ATC

clarithromycin; systemic

1.2

31.7

5523

46121

M66.0

ICD-10 Finland

Rupture of popliteal cyst

2.5

31.7

264

1054

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.4

31.7

1538

10787

R33

ICD-10 Finland

Retention of urine

1.4

31.5

1500

10481

XF402

NOMESCO Finland

ECG with work load test

1.3

31.5

2053

15145

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

31.4

532

2865

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

1.5

31.4

1135

7508

Z50.1

ICD-10 Finland

Other physical therapy

1.5

31.4

976

6242

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

3.6

31.3

146

398

205

Kela drug reimbursment

Chronic hypertension

1.2

31.3

5931

49937

RT360

NOMESCO Finland

13.9

31.3

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

31.2

493

2595

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.0

31.1

422

2100

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.7

31.0

652

3758

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.3

31.0

2075

15370

ZX112

NOMESCO Finland

Subcutaneous

2.0

31.0

397

1930

45000

ICD-8 Finland

+∞

30.9

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.1

30.9

358

1671

SPAT1251

SPAT

Organisation of medication

1.7

30.9

699

4119

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.4

30.8

1836

13348

I81

ICD-10 Finland

Portal vein thrombosis

4.7

30.7

106

219

JAL30

NOMESCO Finland

Omentectomy

2.7

30.7

219

803

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.3

30.5

2092

15553

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.1

30.4

349

1621

K28

ICPC

Limited function/disability (K)

2.0

30.3

412

2051

J20

ICD-10 Finland

Acute bronchitis

1.4

30.3

1591

11321

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.2

30.2

4228

34477

L04AA01

ATC

[U] ciclosporin; systemic

2.3

30.2

277

1161

RD210

NOMESCO Finland

2.3

30.1

293

1263

N03AX14

ATC

levetiracetam; systemic

1.9

30.1

433

2202

R10.0

ICD-10 Finland

Acute abdomen

1.8

30.1

518

2807

N05AX08

ATC

risperidone; systemic

1.4

30.1

1383

9603

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.3

30.0

2037

15117

Z00.0

ICD-10 Finland

General medical examination

1.3

30.0

3231

25553

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.5

30.0

949

6090

R03AC12

ATC

salmeterol; inhalant

1.6

29.9

850

5318

GD1CN

NOMESCO Finland

Lung circulation isotope imaging

21.5

29.9

4519X

ICD-9 Finland

Phlebitis and thrombophlebitis, Of unspecified site

+∞

29.9

R03BA01

ATC

beclometasone; inhalant

1.3

29.9

2509

19211

ZZA00

NOMESCO Finland

Split skin graft

1.8

29.9

546

3015

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

29.8

8078

70191

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

29.7

1810

13204

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.0

29.6

392

1933

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

29.6

1784

12993

FB1BC

NOMESCO Finland

Extensive angiography of arteria pulmonalis

16.1

29.6

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

29.4

1384

9650

A03

ICPC

Fever

1.3

29.4

2256

17050

SPAT1172

SPAT

Guidance concerning hydration

1.9

29.3

454

2374

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.4

29.3

1263

8660

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.3

29.3

2114

15835

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.0

29.3

378

1847

K56.7

ICD-10 Finland

Ileus, unspecified

2.2

29.3

319

1451

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.0

29.2

371

1800

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

29.2

1294

8922

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.4

29.2

257

1057

PH7AC

NOMESCO Finland

Lumbal cavography with X-ray

33.7

29.2

M02AA10

ATC

ketoprofen; topical

1.3

29.2

2890

22615

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.6

29.1

723

4370

E000001

ATC

1.3

29.1

3529

28302

TPX15

NOMESCO Finland

Removal of vascular injection port

4.2

29.1

114

268

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.5

28.9

1024

6742

RT172

NOMESCO Finland

8.7

28.9

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

1.8

28.7

527

2918

WX730

NOMESCO Finland

Conventional respirator

2.2

28.7

307

1383

C09AA05

ATC

ramipril; oral

1.2

28.7

4917

40924

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.8

28.7

487

2626

C01DA14

ATC

isosorbide mononitrate; oral

1.3

28.6

3278

26114

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.7

28.5

569

3232

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.6

28.5

787

4888

R81

ICPC

Pneumonia

1.7

28.5

559

3156

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.6

28.5

862

5477

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.0

28.5

395

1983

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.7

28.5

627

3665

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.1

28.4

332

1554

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

28.4

1794

13160

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.4

28.4

1230

8442

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.5

28.4

996

6545

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.6

28.2

700

4229

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.5

28.2

868

5537

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.4

28.2

1204

8241

Z01.7

ICD-10 Finland

Laboratory examination

1.3

28.1

1835

13529

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

28.1

2691

20956

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.3

28.1

269

1154

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

2.0

28.0

364

1783

N03AF01

ATC

carbamazepine; oral, rectal

1.5

27.8

921

5975

J02AC01

ATC

fluconazole; systemic

1.2

27.8

6866

59086

RS220

NOMESCO Finland

2.4

27.7

231

925

R06.4

ICD-10 Finland

Hyperventilation

2.2

27.7

274

1193

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

27.6

7665

66616

G03FA14

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.6

27.6

354

5978

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.6

27.5

201

747

PG1UT

NOMESCO Finland

Percutaneous aspiration throbectomy

4.4

27.5

102

228

C02KX04

ATC

macitentan; oral

16.5

27.4

RT274

NOMESCO Finland

7.6

27.4

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

27.3

5338

44968

K60

ICPC

Cardiovascular, Result test/procedure

2.8

27.3

177

614

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.1

27.3

333

1591

M10.0

ICD-10 Finland

Idiopathic gout

1.7

27.1

566

3258

N06AB03

ATC

fluoxetine; oral

1.3

27.1

2043

15388

A99

ICPC

Disease/condition unspecnature/site

1.4

27.1

1343

9453

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

27.1

1378

9746

N03AG01

ATC

valproic acid; systemic, rectal

1.5

27.0

929

6081

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

3.9

27.0

112

278

M09AX01

ATC

hyaluronic acid; parenteral

1.5

27.0

961

6335

J01CF05

ATC

flucloxacillin; systemic

1.7

27.0

607

3570

A01AB09

ATC

miconazole; local oral

1.4

26.9

1577

11431

I83

ICD-10 Finland

Varicose veins of lower extremities

1.9

26.8

380

1925

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.6

26.7

642

3848

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.6

26.7

193

714

PH9ST

NOMESCO Finland

Intravenous thrombolysis of other vein

36.9

26.7

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

26.6

1317

9266

L03AA14

ATC

lipegfilgrastim; parenteral

2.1

26.6

319

1514

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.4

26.5

1165

8014

R05

ICPC

Cough

1.2

26.5

3745

30517

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

1.7

26.4

604

3570

X57

ICD-10 Finland

Unspecified privation

1.9

26.4

387

1983

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.4

26.4

1347

9530

J01DA06

ATC

[U] cefuroxime; systemic

1.3

26.4

2524

19643

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

26.3

1273

8918

O87.1

ICD-10 Finland

Deep phlebothrombosis in the puerperium

136.5

26.3

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.6

26.3

634

3803

E87.6

ICD-10 Finland

Hypokalaemia

1.7

26.3

533

3045

B01AF03

ATC

edoxaban; oral

2.1

26.3

305

1429

K59.1

ICD-10 Finland

Functional diarrhoea

1.5

26.1

839

5405

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.9

26.1

403

2107

-50

ICPC

Medication/prescr/renewal

1.6

26.1

746

4675

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.5

26.0

204

790

RS222

NOMESCO Finland

2.4

25.9

231

955

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.5

25.8

802

5130

E883A

ICD-9 Finland

Fall into hole or other opening in surface

1.5

25.7

870

5671

V03AE01

ATC

polystyrene sulfonate; oral

2.3

25.6

241

1025

SPAT1125

SPAT

Stoma care and guidance

2.1

25.6

307

1458

S70.0

ICD-10 Finland

Contusion of hip

1.6

25.6

620

3726

D01

ICPC

Abdominal pain/cramps general

1.4

25.5

1577

11526

N02AC04

ATC

dextropropoxyphene; oral

1.6

25.5

758

4798

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.6

25.4

607

3631

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

25.3

689

4264

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.8

25.3

431

2330

N18.0

ICD-10 Finland

End-stage renal disease

2.3

25.3

236

1002

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.8

25.1

476

2662

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3964

20582

2.02

320.26

9.0

7.5

g/l

121.2

120.8

0.50

3837

19838

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6878

42752

1.75

314.94

4.7

3.8

ng/l

291.0

501.9

3.93

5685

34351

(3020779) Urea [Moles/volume] in Serum or Plasma

3746

19191

2.04

313.64

8.6

6.8

mmol/l

10.5

10.4

0.22

3542

18141

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4959

28094

1.87

308.24

7.4

5.4

mmol/l

1.0

0.45

4654

25888

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

394

442

8.76

307.71

1.2

1.1

—

(4306422)

2434

1633

15.80

307.65

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

14056

99265

1.78

307.65

8.5

5.7

mmol/l

1.2

14.48

13017

89162

(3018010) Neutrophils/100 leukocytes in Blood

13812

98361

1.74

307.65

7.6

5.8

59.0

57.7

28.47

13057

91296

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4692

24404

2.05

307.65

2.1

1.7

—

(3006315) Basophils [#/volume] in Blood

14561

104003

1.78

307.65

7.5

5.6

e9/l

0.0

1.37

12652

89188

(3032080) INR in Blood by Coagulation assay

14790

89243

2.34

307.65

14.6

9.1

inr

1.4

1.3

4.52

4348

24745

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

2360

1575

15.84

307.65

1.1

119.4

117.6

1.11

2073

1441

(3022096) Basophils/100 leukocytes in Blood

13503

94291

1.78

307.65

7.9

5.9

0.6

0.7

14.92

12747

87339

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

2083

1842

11.81

307.65

1.3

1.2

u/ml

3.9

3.7

0.24

892

850

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4999

25041

2.15

307.65

7.9

6.7

kpa

5.1

0.39

4752

23819

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

11400

42532

3.77

307.65

2.4

1.6

mg/l

1.9

1.2

63.34

9276

32603

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2793

4406

6.75

307.65

2.7

2.3

197.6

193.8

1.19

2585

4194

(3023368) Bacteria identified in Blood by Culture

10737

59953

2.22

307.65

5.8

4.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6138

33095

2.03

307.65

3.0

1.9

30.7

29.9

13.23

5960

32079

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

740

474

15.55

307.65

1.1

97.7

95.9

0.52

580

372

(4268621)

1405

1238

11.56

307.65

2.5

2.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4702

24426

2.05

307.65

2.1

1.7

—

(3001604) Monocytes [#/volume] in Blood

14508

103422

1.78

307.65

7.5

5.6

e9/l

0.6

3.61

12605

88664

(3036489) Thrombin time

3588

6158

6.37

307.65

2.3

1.9

21.5

21.7

0.62

2820

5579

(3018418) pH of Serum or Plasma

9604

64881

1.68

307.65

5.7

4.0

7.4

0.90

2129

12060

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6604

35617

2.06

307.65

2.2

1.8

—

(3006504) Eosinophils/100 leukocytes in Blood

13801

97087

1.77

307.65

7.9

5.8

2.7

2.9

17.07

13027

89848

(3034426) Prothrombin time (PT)

478

414

11.39

307.65

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

3382

4622

7.97

307.65

2.4

2.1

96.3

88.5

54.04

3023

4375

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6356

34490

2.03

307.65

4.4

3.1

mmol/l

0.8

10.49

5996

31867

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

830

748

11.08

307.65

1.2

1.1

ratio

1.1

1.70

278

262

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

842

650

12.94

307.65

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

2357

1675

14.86

307.65

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

9219

53520

2.02

307.65

5.4

3.8

86.2

88.6

13.63

8883

52240

(3013826) Glucose [Moles/volume] in Serum or Plasma

16790

126253

1.76

307.65

6.9

4.6

mmol/l

6.8

0.47

16082

118220

(3024561) Albumin [Mass/volume] in Serum or Plasma

13420

94837

1.74

307.65

6.7

4.6

g/l

33.8

35.2

135.43

12546

87407

(3013115) Eosinophils [#/volume] in Blood

14842

107348

1.76

307.65

7.9

5.8

e9/l

0.2

11.66

13072

93362

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

15128

109580

1.77

307.65

9.6

6.4

mmol/l

1.2

9.19

12779

91819

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

429

451

9.36

307.65

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

4994

25027

2.15

307.65

7.9

6.7

kpa

11.5

12.3

21.52

4736

23805

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

1732

1187

15.06

307.65

1.2

1.1

95.2

96.2

0.51

1576

1131

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2185

1874

12.22

307.65

1.3

1.2

u/ml

4.0

0.01

683

701

(3022217) INR in Platelet poor plasma by Coagulation assay

6279

29935

2.35

307.65

35.6

25.4

inr

1.6

1.4

12.36

647

4267

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2026

5201

4.01

307.65

3.3

2.3

g/l

3.6

0.28

1932

4935

(3002030) Lymphocytes/100 leukocytes in Blood

14063

99884

1.76

307.65

8.0

6.0

25.8

27.3

43.11

13257

92315

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

15700

111792

1.86

307.65

9.2

5.9

umol/l

11.1

11.7

6.89

15070

105689

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

527

639

8.14

307.65

1.2

1.1

u/ml

22.3

10.2

0.54

(3019198) Lymphocytes [#/volume] in Blood

14786

106243

1.77

307.65

7.6

5.7

e9/l

1.8

1.9

7.37

13054

92662

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12012

84156

1.69

307.65

4.9

3.7

ng/l

53.9

70.2

0.50

9148

59746

(3019069) Monocytes/100 leukocytes in Blood

13865

97591

1.78

307.65

8.2

6.1

8.7

0.04

13111

90720

(42870588) Differential panel, method unspecified - Blood

10905

71585

1.80

307.65

7.4

5.7

—

(3016502) Oxygen saturation in Arterial blood

4420

22429

2.09

307.65

8.3

7.1

95.1

95.6

4.35

4254

21575

(3042936) Bacteria identified in Isolate by Culture

5363

30030

1.91

307.65

2.4

2.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10742

65822

1.97

307.65

3.5

3.0

ng/l

1520.3

1585.9

0.63

9499

56376

(3013650) Neutrophils [#/volume] in Blood by Automated count

16385

120169

1.82

307.65

13.4

8.6

e9/l

4.3

4.2

5.14

14560

104262

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

3305

6523

5.46

307.65

3.6

2.7

u/ml

0.4

0.3

5.22

2172

3531

(3003396) Base excess in Arterial blood by calculation

4991

25044

2.15

307.65

7.9

6.7

mmol/l

1.2

1.0

2.32

4002

19644

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4581

25332

1.91

306.72

4.8

4.0

u/l

252.9

244.6

2.83

4367

23794

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5214

30095

1.84

305.05

3.1

2.5

20.9

22.3

9.90

4526

25382

(3019060) Gas panel - Arterial blood

3038

14532

2.16

304.59

5.1

4.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5472

32195

1.81

300.14

3.0

2.4

g/l

2.3

4.42

5102

29528

(3022948) Iron [Moles/volume] in Serum or Plasma

5799

34807

1.79

297.05

3.0

2.5

umol/l

11.7

12.7

22.10

5410

31957

(3002582) Erythrocytes [#/volume] in Urine

9599

66084

1.63

294.95

4.3

3.3

e6/l

101.1

98.1

0.07

7640

50706

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

20021

164699

1.69

294.32

11.8

7.3

u/l

82.3

79.2

11.35

19182

154304

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3166

15850

2.06

280.19

1.9

1.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

4778

27512

1.83

278.91

8.6

6.6

mmol/l

104.5

104.3

1.62

4641

26901

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2666

12555

2.18

276.70

7.7

6.5

mmol/l

24.8

0.17

2640

12428

(3030467) Casts [#/volume] in Urine by Automated count

8872

60649

1.62

275.95

4.2

3.2

e6/l

0.5

0.4

1.27

6954

45705

(3000991) Gas panel - Venous blood

3450

18020

1.98

270.62

9.5

7.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3586

19105

1.95

265.14

8.0

6.4

mmol/l

1.4

0.01

3439

18357

(3044640) Blood type and Crossmatch panel - Blood

9625

67693

1.59

262.66

3.1

2.4

—

(3018095) Leukocytes [#/volume] in Urine

10621

76425

1.57

262.59

5.0

3.7

e6/l

117.0

108.4

0.36

8003

54558

(3026008) Bacteria identified in Urine by Culture

9556

67131

1.59

261.84

4.0

3.2

—

(36304419) Bacteria [Presence] in Urine

8552

58542

1.61

261.14

4.1

3.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

9585

67621

1.58

256.52

3.2

2.5

u/l

53.6

59.5

16.57

8962

62079

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3674

20201

1.89

245.47

4.7

3.7

kpa

5.9

5.8

3.30

3553

19591

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2416

11465

2.15

244.54

9.6

8.5

mmol/l

24.5

24.3

1.70

2233

10616

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

8070

55227

1.60

242.77

2.6

2.3

mg/l

3.3

3.0

19.98

6970

46791

(3002032) Base excess in Venous blood by calculation

3657

20177

1.88

241.42

4.7

3.7

mmol/l

2.1

1.9

2.39

3044

16423

(3026782) Osmolality of Urine

6605

43121

1.64

240.67

3.7

2.8

mosm/kgh2o

534.5

546.2

4.47

5780

36558

(40758558) Short blood count panel - Blood

7754

52820

1.60

236.59

10.1

6.6

—

(3012544) pH of Venous blood

3749

20991

1.85

235.81

4.7

3.7

7.4

0.00

100

(3031040) Bacteria [#/volume] in Urine by Automated count

17389

141501

1.54

233.22

6.2

4.6

e6/l

1392.2

1523.3

0.14

294

2093

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

12920

98906

1.51

230.10

5.1

4.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

4252

24913

1.78

229.64

2.1

1.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1954

8845

2.23

221.77

2.3

1.9

ug/l

2.7

2.2

0.22

1723

7723

(3000850) Epithelial cells [#/volume] in Urine

6881

46236

1.60

219.25

3.4

2.6

e6/l

5.6

5.3

0.97

6114

40336

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3980

23288

1.77

214.60

4.8

3.8

ug/l

33.8

22.5

1.36

3302

19020

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2549

12939

2.01

213.93

4.4

3.4

mmol/l

2.0

1.8

2.11

1945

9560

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2664

13793

1.97

211.15

7.8

6.9

mmol/l

24.8

24.6

2.48

2493

12865

(3009343) pH of Capillary blood

2609

13442

1.98

209.67

4.4

3.5

7.4

0.43

434

1720

(3015377) Calcium [Moles/volume] in Serum or Plasma

10021

73729

1.51

209.53

4.7

3.3

mmol/l

2.3

2.4

8.42

8828

63361

(3021589) Normoblasts [#/volume] in Blood

11973

91363

1.49

209.14

14.3

9.6

e9/l

0.0

0.89

9809

74760

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2633

13624

1.97

208.96

4.4

3.5

kpa

5.2

0.10

2452

12481

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2499

12736

2.00

207.05

1.7

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1247

4812

2.59

201.78

1.8

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9145

66477

1.51

200.21

4.2

3.1

u/l

33.9

34.9

0.76

8651

62688

(3010421) pH of Blood

1372

5582

2.46

198.50

5.0

3.8

7.4

0.67

1201

4744

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2538

13191

1.96

198.31

1.9

1.7

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2615

13735

1.94

198.07

10.1

8.4

93.4

93.8

3.48

2604

13683

(3027315) Oxygen [Partial pressure] in Blood

1249

4887

2.55

196.31

5.0

3.9

kpa

8.4

8.5

0.60

1222

4760

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2602

13728

1.93

194.29

10.0

8.4

0.7

0.21

2582

13636

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2600

13750

1.92

192.68

10.0

8.3

1.4

0.34

2579

13653

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

259

312

8.13

190.97

1.2

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3376

19444

1.78

190.31

3.2

2.9

ng/l

202.5

227.6

2.39

3090

17777

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1193

4641

2.56

189.67

1.9

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2293

11679

1.99

189.57

11.0

9.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7349

51546

1.53

188.02

3.0

2.3

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1228

4866

2.52

187.82

5.0

3.9

kpa

5.0

0.01

1201

4740

(3012501) Base excess in Blood by calculation

1227

4865

2.52

187.42

5.0

3.9

mmol/l

2.7

2.6

0.36

897

3289

(3027945) Reticulocytes/100 erythrocytes in Blood

4145

25501

1.68

183.81

3.1

2.3

1.9

1.8

12.59

3662

22288

(3037467) Urinalysis macro (dipstick) panel - Urine

17572

146558

1.47

182.29

5.9

4.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5304

34788

1.60

181.87

3.7

3.0

e6/l

2.8

2.7

0.36

2970

18981

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2017

9956

2.04

181.76

4.8

3.9

mmol/l

24.2

24.1

0.72

1829

8901

(3024354) Oxygen [Partial pressure] in Venous blood

2940

16593

1.81

176.55

3.9

3.0

kpa

4.6

4.5

1.46

2829

16012

(3020630) Protein [Mass/volume] in Serum or Plasma

3202

18540

1.77

176.28

3.1

2.5

g/l

65.1

66.5

17.63

2933

16654

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3906

23976

1.68

173.81

3.3

2.6

umol/l

9.3

9.0

0.24

3398

20769

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

9040

67212

1.46

169.23

2.5

2.1

u/l

210.3

210.9

0.02

8517

62678

(40767503) Oxygen content in Capillary blood by calculation

1133

4545

2.48

168.56

2.9

2.5

16.2

0.01

565

2391

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5543

37577

1.54

161.83

3.4

2.8

e6/l

1.3

1.2

0.24

3200

21600

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

996

3839

2.58

161.07

6.9

5.1

iu/ml

4299.1

1445.0

0.37

178

562

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3260

19431

1.71

160.87

2.9

2.4

u/l

47.3

45.6

0.07

2815

16543

(3001122) Ferritin [Mass/volume] in Serum or Plasma

11201

87328

1.42

158.77

3.5

2.8

ug/l

164.8

139.2

8.06

10353

79945

(1616796) Gas panel - Central venous blood

1154

4816

2.38

157.24

4.3

3.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

7803

57060

1.46

156.39

3.4

2.6

umol/l

4585.5

4996.6

0.37

6728

48810

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3308

20031

1.69

153.42

2.4

2.2

g/l

0.2

3.52

3053

18503

(3028271) Lactate [Moles/volume] in Capillary blood

890

3335

2.64

152.35

2.2

1.8

mmol/l

1.7

1.42

873

3260

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

923

3522

2.60

152.30

1.9

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3046

18208

1.70

147.86

2.5

2.2

nmol/l

364.9

376.9

2.27

2840

16627

(3022806) Fractional oxyhemoglobin in Capillary blood

755

2658

2.81

145.84

2.1

1.8

89.3

89.5

0.24

743

2623

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3552

22182

1.64

145.57

4.7

3.4

—

(3017181) Myelocytes/100 leukocytes in Blood

2969

17744

1.70

143.99

4.6

3.9

1.0

0.27

1150

4962

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1557

7629

2.04

142.15

2.5

2.2

ug/l

444.2

568.4

0.80

1474

7164

(3023520) Reticulocytes [#/volume] in Blood

3109

19092

1.66

135.43

3.2

2.5

e9/l

73.2

68.6

9.14

2275

14572

(44806071)

161

169

9.30

132.31

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5791

41101

1.47

131.27

4.2

3.0

mmol/l

2.5

15.36

5066

35674

(4035726)

3050

18791

1.65

130.86

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

880

3547

2.46

129.21

1.6

1.4

—

(3019174) dRVVT (LA screen)

126

100

12.28

125.22

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1722

9128

1.89

124.56

1.7

1.5

u/ml

16.8

15.1

0.17

220

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1325

6418

2.06

124.48

1.4

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

2776

16898

1.66

124.45

4.7

4.0

0.1

0.13

1067

4599

(3002179) Metamyelocytes/100 leukocytes in Blood

2669

16084

1.68

124.37

4.5

3.8

0.8

0.6

1.42

825

3554

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1523

7768

1.96

123.68

4.0

3.2

u/ml

6536.9

1449.0

0.66

1281

6637

(3028626) Oxygen [Partial pressure] in Capillary blood

1063

4740

2.22

123.62

3.3

2.8

kpa

8.1

8.0

1.01

1000

4368

(3022313) Gas panel - Capillary blood

1801

9715

1.86

123.30

4.7

3.6

—

(3044009) aPTT.lupus sensitive (LA screen)

124

100

12.09

122.02

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1297

6284

2.05

121.72

1.9

1.6

—

(3013707) Erythrocyte sedimentation rate by Westergren method

18103

156386

1.37

121.56

5.3

4.1

mm/h

15.6

12.9

80.68

16894

143663

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

759

2940

2.55

121.24

3.1

2.5

u/ml

10675.4

4779.4

0.26

165

(3005719) IgG [Mass/volume] in Serum or Plasma

2489

14879

1.69

119.31

3.6

2.6

g/l

10.2

10.7

5.08

2319

13532

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

719

2749

2.58

117.97

1.7

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

623

2237

2.74

115.81

1.8

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1050

4787

2.17

115.47

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1049

4786

2.17

115.14

1.5

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

772

3094

2.46

114.68

1.6

1.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

720

2796

2.54

114.37

6.8

6.0

mg/l

11.8

11.9

0.07

658

2536

(40760892) CBC W Ordered Manual Differential panel - Blood

6035

44105

1.42

114.33

5.8

4.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1164

5554

2.08

113.72

3.5

3.0

mmol/l

24.8

0.03

1046

4845

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1462

7573

1.92

113.18

2.9

2.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

702

2710

2.55

112.89

1.6

1.3

—

(3018405) Lactate [Moles/volume] in Arterial blood

1476

7729

1.90

110.51

4.4

4.0

mmol/l

1.4

0.32

1445

7585

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1179

5768

2.03

107.52

1.9

1.6

g/l

0.2

2.65

1116

5427

(3025159) Blasts/100 leukocytes in Blood

2565

15850

1.63

107.47

4.7

4.0

0.1

0.3

1.84

904

3868

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1843

10425

1.77

107.35

2.0

1.6

g/l

1.7

1.6

4.90

1603

8813

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1025

4775

2.13

106.58

1.6

1.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1204

5954

2.01

106.53

1.8

1.6

g/l

1.2

2.66

1145

5630

(3035350) Ketones [Presence] in Urine by Test strip

12521

103522

1.32

105.58

4.8

3.7

estimate

0.0

1.28

2758

18720

(3004588) Protein electrophoresis panel - Serum or Plasma

2507

15501

1.63

104.63

2.8

2.3

—

(3021901) Oxygen saturation in Capillary blood

905

4049

2.21

104.21

3.2

2.8

—

(3004809) Band form neutrophils/100 leukocytes in Blood

813

3480

2.31

104.10

3.4

3.3

1.6

1.5

0.26

641

2671

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2831

18092

1.58

102.83

5.7

3.6

mmol/l

1.2

1.76

2560

15637

(3021601) Nitrite [Presence] in Urine by Test strip

12514

103792

1.32

101.62

6.5

5.0

estimate

0.0

2.81

2785

19073

(3009261) Glucose [Presence] in Urine by Test strip

12637

104987

1.32

101.24

4.9

3.8

estimate

0.0

0.07

2725

18612

(3004119) Hemoglobin [Mass/volume] in Venous blood

2207

13328

1.66

100.96

4.2

3.2

g/l

125.8

128.3

5.66

2159

13004

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1531

8354

1.83

100.44

5.0

3.8

mmol/l

25.1

24.9

1.84

1420

7618

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

699

2844

2.42

100.42

1.6

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

868

3876

2.21

100.40

3.6

3.2

e9/l

4.3

4.2

0.20

863

3868

(46235355) HIV 1 and 2 tests - Meaningful Use set

3928

27143

1.47

98.59

1.8

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2624

16723

1.58

96.07

4.6

3.7

ng/l

104.2

92.2

6.84

2287

14162

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1337

7130

1.86

94.29

1.8

1.6

titre

240.8

246.5

0.03

324

(3017143) Hepatitis C virus Ab [Presence] in Serum

2988

19707

1.53

93.69

1.7

1.6

—

(3015736) pH of Urine

9983

80881

1.31

93.30

4.4

3.5

5.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1144

5827

1.95

92.78

1.7

1.4

iu/ml

15.7

15.1

0.06

125

(3037522) Nuclear Ab [Titer] in Serum

3856

26891

1.46

91.65

1.4

1.3

titre

573.0

537.8

0.51

833

5744

(3028026) IgM [Mass/volume] in Serum or Plasma

1947

11673

1.67

91.23

2.3

1.9

g/l

1.2

1.4

1.83

1790

10532

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1608

9168

1.75

90.66

6.2

4.8

1.6

0.00

1490

8614

(3020891) Body temperature

1556

8800

1.76

90.24

5.4

4.7

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1756

10297

1.70

89.41

3.4

2.7

1.3

1.2

0.45

1748

10244

(3007930) Methemoglobin/Hemoglobin.total in Blood

1583

9022

1.75

89.34

6.2

4.8

0.9

0.01

1473

8468

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2997

19983

1.51

88.97

2.5

2.4

ug/l

6.9

7.1

0.12

2534

17164

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

22861

208346

1.42

88.85

27.3

14.7

mg/l

26.6

24.8

13.24

20732

166505

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

873

4124

2.09

87.36

1.8

1.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

395

1304

2.97

85.81

1.3

1.4

umol/l

12.9

0.03

373

1230

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

10608

87325

1.29

85.66

2.6

2.2

nmol/l

76.6

1138.5

0.50

9535

77364

(3047181) Lactate [Moles/volume] in Blood

1256

6770

1.84

85.46

7.3

5.6

mmol/l

1.3

0.66

1106

5988

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1708

10081

1.69

84.75

3.5

2.7

0.7

0.28

1654

9673

(44806118)

543

2146

2.49

83.08

1.7

1.5

—

(44790048)

543

2147

2.48

83.00

1.7

1.5

—

(44790047)

543

2147

2.48

83.00

1.7

1.5

—

(44790049)

543

2147

2.48

83.00

1.7

1.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

5821

44207

1.35

82.96

1.9

1.8

nmol/l

1165.2

1165.6

0.01

4490

32952

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1508

8660

1.73

82.69

2.6

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1509

8673

1.73

82.49

2.6

2.2

g/l

7.5

7.4

1.13

1123

6336

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1504

8646

1.73

82.15

2.6

2.2

g/l

3.9

3.8

0.78

1078

6069

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

450

1638

2.69

81.48

1.7

1.4

—

(3000494) Fungus identified in Specimen by Culture

3481

24305

1.45

81.34

1.7

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

1230

6718

1.81

80.09

4.7

4.3

mmol/l

3.9

0.26

1128

6319

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

418

1483

2.76

79.54

1.9

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1416

8092

1.74

78.93

2.6

2.2

g/l

10.1

10.3

0.55

1189

6666

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

906

4503

1.99

78.77

3.9

3.1

u/ml

2009.7

676.2

1.46

819

4099

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1306

7316

1.77

78.05

2.9

2.4

g/l

1.1

1.0

0.40

1122

6161

(3021960) Folate [Moles/volume] in Serum or Plasma

6691

52285

1.32

77.60

1.7

1.6

nmol/l

19.3

20.5

9.33

5849

44370

(3006184) Hemoglobin [Mass/volume] in Capillary blood

980

5041

1.92

77.03

2.5

2.2

g/l

128.2

128.4

0.07

743

3619

(3027273) Bicarbonate [Moles/volume] in Venous blood

1780

10876

1.63

76.97

4.5

3.3

mmol/l

25.3

25.2

0.86

1728

10566

(3003434) Protein [Mass/volume] in Pleural fluid

686

3112

2.17

76.21

1.4

1.5

g/l

33.5

32.3

1.76

621

2789

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1407

8110

1.72

75.99

2.6

2.2

g/l

3.2

3.1

3.12

1101

6197

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3321

23322

1.44

74.71

1.7

1.6

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1654

10026

1.64

73.75

4.9

3.9

49.1

47.7

1.65

1639

9909

(3052851) Hemolysis interference index of Serum or Plasma

1199

6665

1.78

73.51

4.0

3.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1158

6377

1.80

73.27

2.5

2.2

g/l

0.0

0.66

1063

5764

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1256

7090

1.75

73.02

4.0

3.1

ratio

9.9

3.5

0.51

549

(3034860) Kappa light chains.free [Mass/volume] in Serum

1286

7312

1.74

72.88

4.1

3.1

mg/l

60.2

67.6

0.32

1022

5905

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1282

7302

1.74

72.19

4.1

3.1

mg/l

48.5

44.0

0.19

1014

5896

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1547

9344

1.64

69.86

2.4

1.9

—

(3045788) Cell count panel - Pleural fluid

505

2090

2.37

69.85

1.5

—

(3039000) Anion gap in Blood

924

4844

1.88

68.48

8.1

6.5

mmol/l

11.1

11.2

0.31

824

4366

(3018572) Chloride [Moles/volume] in Blood

924

4845

1.88

68.44

8.1

6.5

mmol/l

105.2

105.0

0.41

824

4367

(40761536) Microorganisms panel - Urine sediment

2583

17575

1.47

68.26

5.4

4.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

610

2770

2.16

67.59

1.5

e6/l

3359.2

2574.1

0.31

439

2012

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1183

6712

1.74

67.48

2.5

2.2

g/l

36.4

37.5

8.03

1022

5647

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

977

5258

1.83

66.62

3.8

2.8

mg/l

1.9

1.6

10.18

895

4757

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1072

5937

1.78

66.47

2.5

2.3

g/l

0.0

2.08

979

5350

(3023183) Ammonium ion [Moles/volume] in Plasma

858

4442

1.90

66.08

2.7

2.6

umol/l

32.4

34.0

1.19

715

3715

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1057

5847

1.79

65.80

2.6

2.3

g/l

0.0

0.00

978

5331

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

10884

92004

1.25

63.94

2.2

2.0

pmol/l

92.8

95.4

7.04

6087

47429

(3012441) Differential panel - Pleural fluid

537

2385

2.21

62.91

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1412

8576

1.63

62.22

2.1

1.8

—

(3025941) Bacteria identified in Stool by Culture

1766

11308

1.55

62.18

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

320

1131

2.77

61.43

1.8

1.4

—

(3013512) EKG study

7851

64257

1.26

60.18

4.8

4.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

552

2526

2.14

60.00

1.5

e6/l

57609.4

55395.8

0.07

332

1508

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

486

2115

2.25

59.84

1.9

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

316

1126

2.74

59.74

1.8

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1606

10159

1.57

59.61

5.2

3.4

u/ml

89.0

59.5

1.80

1541

9790

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

348

1304

2.61

59.58

1.7

1.4

—

(3023419) Bacteria identified in Sputum by Culture

579

2711

2.10

59.29

2.6

2.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

480

2096

2.24

58.63

1.3

1.4

mmol/l

6.0

6.4

2.19

444

1939

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

15108

133055

1.23

58.22

3.9

3.1

u/l

60.1

50.8

18.66

14090

122743

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

932

5150

1.78

58.18

1.7

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

6229

49745

1.28

58.10

4.5

3.8

—

(3042631) Mycobacterium sp identified in Specimen

632

3081

2.01

58.00

2.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

711

3612

1.94

57.95

1.6

1.4

—

(3024928) Oxygen saturation in Venous blood

832

4449

1.84

57.88

3.6

3.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

456

1982

2.25

56.33

1.7

1.5

iu/ml

44.6

24.1

1.27

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

455

1981

2.25

55.98

2.0

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1921

12800

1.49

55.90

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

250

820

2.98

55.10

31.5

27.2

ug/l

111.5

113.1

0.15

212

690

(40760888) Immunoglobulin light chains.free panel - Serum

966

5486

1.74

54.81

4.4

3.1

—

(40768806) Pleura Pathology biopsy report

521

2416

2.11

54.74

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

866

4782

1.78

54.17

1.3

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

664

3375

1.93

54.04

1.3

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

644

3242

1.95

53.93

1.6

1.4

u/ml

112.1

116.9

0.62

151

743

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

631

3156

1.96

53.85

1.3

1.2

u/ml

285.9

282.4

0.10

422

2002

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

574

2785

2.02

53.40

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

421

1813

2.27

53.20

1.9

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

421

1813

2.27

53.20

1.9

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

421

1813

2.27

53.20

1.9

1.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

691

3596

1.89

52.37

1.6

1.4

u/ml

14.9

22.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

327

1267

2.52

52.31

2.0

—

(3011412) CD3 cells [#/volume] in Blood

413

1783

2.27

51.89

2.2

2.3

e9/l

1.1

0.25

269

1057

(3007164) IgA [Mass/volume] in Serum or Plasma

4695

36696

1.29

50.86

1.8

1.4

g/l

2.5

0.04

2935

21514

(3026250) Tacrolimus [Mass/volume] in Blood

232

766

2.96

50.58

39.1

32.8

ug/l

7.1

7.3

0.53

217

679

(40768797) Stomach Pathology biopsy report

3869

29484

1.32

50.55

1.3

1.2

—

(3044889) 12 lead EKG panel

16608

148699

1.22

50.39

4.6

3.9

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

889

5073

1.72

49.56

1.3

1.2

—

(3019977) pH of Arterial blood

311

1208

2.52

49.52

2.5

7.4

1.11

120

435

(3037121) Protein [Mass/volume] in Urine

1200

7419

1.60

48.97

4.1

2.9

g/l

0.4

0.3

0.64

620

3043

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

271

993

2.67

48.62

1.9

2.0

100.7

96.4

1.06

246

928

(21494815) CD4 cells/100 lymphocytes in Specimen

368

1557

2.31

48.51

2.0

2.1

38.4

40.4

0.22

215

(3029937) Albumin [Presence] in Urine by Test strip

6883

56618

1.24

48.04

5.4

4.2

estimate

0.0

0.19

2639

18228

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

13382

117756

1.20

47.03

3.1

2.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

489

2359

2.03

46.27

4.4

3.6

—

(40768804) Tissue Pathology biopsy report

10025

85952

1.21

46.10

2.3

2.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

326

1341

2.38

45.86

2.0

1.9

13.9

15.1

0.60

131

572

(1175426) CD3 cells/100 lymphocytes in Blood

329

1372

2.34

44.88

2.0

73.1

72.0

0.56

318

1307

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

436

2044

2.09

44.59

3.0

2.8

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

456

2208

2.02

42.73

3.7

3.3

60.6

58.6

1.00

312

1389

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

541

2780

1.91

42.67

1.9

1.8

ug/l

23.7

23.5

0.04

531

2712

(3021788) Differential panel - Synovial fluid

708

3970

1.75

42.02

1.6

1.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

329

1412

2.28

42.01

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

328

1410

2.27

41.72

1.2

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

317

1344

2.30

41.66

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

328

1411

2.27

41.66

1.2

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

274

1089

2.46

41.63

2.2

1.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

326

1401

2.27

41.50

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

326

1401

2.27

41.50

1.2

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

6609

54816

1.23

41.42

4.7

3.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

273

1089

2.45

41.16

2.2

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

273

1089

2.45

41.16

2.2

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

273

1089

2.45

41.16

2.2

1.8

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

325

1400

2.27

41.15

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

444

2166

2.01

40.77

3.8

3.7

—

(3037756) Immunofixation for Serum or Plasma

826

4882

1.66

40.39

1.8

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

962

5917

1.60

40.07

1.6

iu/ml

0.2

9.8

2.03

238

1329

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

228

847

2.63

39.90

2.4

1.9

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1018

6360

1.58

39.67

1.4

ug/g

253.7

268.1

1.41

613

3705

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

459

2292

1.96

39.45

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

602

3281

1.80

39.39

4.5

3.4

u/ml

41.2

38.5

0.19

582

3165

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

9295

79949

1.20

39.36

5.3

4.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

438

2158

1.99

39.13

1.3

u/l

504.4

480.5

0.11

409

2041

(3042111) Morphology [Interpretation] in Bone marrow Narrative

641

3581

1.76

38.56

1.8

1.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

138

394

3.41

38.45

1.5

1.2

mg/l

147.9

17.3

1.35

301

(3005322) IgE [Units/volume] in Serum or Plasma

1669

11605

1.42

38.41

1.4

1.3

u/ml

199.2

236.6

1.08

1536

10691

(3022145) Colonoscopy Study observation

3096

23692

1.30

38.35

1.4

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

223

837

2.60

38.24

2.4

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

223

837

2.60

38.24

2.4

1.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1295

8598

1.49

38.04

2.0

1.9

u/l

38.2

39.1

0.82

1145

7470

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

165

4.89

37.65

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

465

2372

1.92

37.54

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

356

1665

2.09

36.73

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

353

1647

2.09

36.65

1.5

1.4

u/l

12.2

13.2

1.62

334

1590

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

360

1699

2.07

36.26

1.3

u/l

11.9

13.7

1.43

324

1572

(3035880) pH of Pleural fluid

289

1252

2.25

36.16

1.3

—

(3010503) CD19 cells [#/volume] in Blood

277

1181

2.29

36.00

2.3

2.5

e9/l

0.3

0.4

0.32

270

1139

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

365

1743

2.05

35.62

2.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

949

5989

1.56

35.38

1.2

—

(3004451) EKG impression Narrative

257

1069

2.35

35.38

1.4

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

947

6001

1.55

34.66

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

593

3346

1.74

34.48

1.6

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

565

3145

1.76

34.46

1.6

g/l

0.8

0.41

429

2344

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

113

307

3.58

34.01

1.4

1.2

—

(3045142) Bone marrow Pathology biopsy report

448

2333

1.88

34.00

1.4

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

856

5329

1.58

33.88

1.7

1.6

e6/l

15874.0

13970.6

0.46

592

3865

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

714

4255

1.65

33.84

1.4

1.2

titre

227.5

114.6

0.51

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

934

5940

1.54

33.64

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

251

1063

2.30

33.19

1.2

—

(4010399)

2091

15448

1.34

33.01

1.5

1.4

—

(3000492) Spirometry study

2448

18499

1.31

32.98

1.6

1.5

—

(3002385) Erythrocyte distribution width [Ratio]

18448

169375

1.18

32.82

31.6

17.9

14.2

13.8

204.68

18157

165607

(3037692) Legionella sp identified in Specimen by Organism specific culture

192

724

2.59

32.70

1.5

1.4

—

(3017569) Oxygen content in Arterial blood

237

989

2.34

32.44

2.4

2.1

—

(3044941) Cell count panel - Synovial fluid

590

3386

1.71

32.29

1.6

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

240

1011

2.32

32.15

2.1

2.0

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

23101

216649

1.24

31.97

29.8

17.3

mmol/l

139.5

139.6

12.68

22748

210894

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4263

34576

1.23

31.89

1.3

iu/ml

40.3

37.4

0.24

1321

10830

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

180

666

2.63

31.87

1.9

1.7

u/ml

13484.4

39446.8

0.63

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

201

788

2.49

31.59

1.9

1.7

178.0

153.2

3.21

184

730

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

169

610

2.70

31.42

1.9

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

650

3860

1.65

31.26

4.3

3.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

328

1589

2.02

30.84

1.2

titre

90.0

150.6

0.76

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

155

541

2.79

30.74

1.1

88.8

87.8

0.13

244

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

328

1592

2.01

30.68

1.2

titre

186.8

169.1

0.17

281

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

825

5216

1.55

30.52

1.4

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

794

4982

1.56

30.39

1.3

u/ml

9.6

5.9

0.36

519

(4062490)

384

1977

1.90

30.25

1.5

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1148

7788

1.45

30.14

1.3

1.2

u/ml

0.9

0.11

111

727

(3048689) Calprotectin [Mass/mass] in Stool

2960

23183

1.27

30.04

2.5

2.2

ug/g

163.1

140.0

2.38

2387

17905

(40768446) Kidney Pathology biopsy report

185

715

2.52

29.99

1.7

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

189

739

2.49

29.90

2.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

748

4647

1.58

29.90

1.5

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

383

1981

1.89

29.75

1.5

1.4

g/l

6.5

6.9

1.36

272

1362

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

800

5056

1.55

29.66

1.3

u/ml

8.1

6.9

0.22

144

805

(3051651) Icteric interference index of Serum or Plasma

275

1268

2.12

29.56

5.0

3.8

—

(3013727) Leukocytes other/100 leukocytes in Blood

177

676

2.55

29.42

3.5

56.7

53.4

1.22

171

651

(3023103) Potassium [Moles/volume] in Serum or Plasma

23118

217166

1.23

29.39

30.0

17.4

mmol/l

4.0

16.69

22746

211025

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

161

587

2.67

29.39

1.9

1.8

213.3

176.2

2.82

153

549

(3024139) IgG subclass 3 [Mass/volume] in Serum

381

1982

1.88

29.09

1.5

1.4

g/l

0.4

1.46

270

1366

(3028192) IgG subclass 2 [Mass/volume] in Serum

380

1984

1.87

28.69

1.5

1.4

g/l

2.7

3.0

1.70

270

1364

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

926

6084

1.49

28.63

2.0

1.8

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

392

2069

1.85

28.60

4.2

3.7

u/ml

73.7

48.4

1.28

386

2035

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

335

1681

1.95

28.53

2.3

1.8

mg/l

4.1

4.0

0.24

320

1589

(3001964) Herpes simplex virus Ag [Presence] in Specimen

153

553

2.69

28.43

1.6

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

121

386

3.05

28.26

2.5

2.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

844

5480

1.51

27.64

1.3

1.2

u/ml

36.4

41.8

0.23

326

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

900

5922

1.49

27.63

1.5

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

207

875

2.31

27.59

3.4

4.3

mg/l

752.9

1254.6

0.26

161

601

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.79

27.33

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

459

2577

1.74

27.26

21.4

8.0

mmol/l

7.6

7.5

0.07

394

2098

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

484

2762

1.71

27.11

2.5

2.6

u/ml

115.0

988.5

1.67

472

2685

(40762365) Oxygen content in Arterial blood by calculation

112

350

3.11

27.11

2.8

2.6

ml/dl

15.0

14.9

0.24

104

321

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

500

2880

1.70

27.07

2.9

2.0

32.4

32.6

0.52

489

2861

(3016650) Hepatitis A virus Ab [Presence] in Serum

516

3002

1.68

26.91

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5628

47548

1.19

26.90

1.7

pmol/l

21295922.0

31049521.2

0.72

4616

38729

(3020876) Protein [Mass/time] in 24 hour Urine

360

1889

1.86

26.80

2.1

1.9

g/24h

0.8

1.1

0.31

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

153

573

2.60

26.53

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

283

1375

2.01

26.47

2.3

2.5

e6/l

1094.0

654.6

0.49

107

579

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

671

4192

1.57

26.22

1.3

1.2

u/ml

8.9

4.3

0.53

312

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1603

11774

1.34

26.18

3.7

2.7

e6/l

0.4

0.3

0.77

1562

11499

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

672

4209

1.56

25.97

1.2

u/ml

5.6

13.4

0.71

(3002256) Pathology report gross observation

3476

28142

1.23

25.95

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3967

32550

1.21

25.93

1.3

u/ml

15.8

13.0

0.62

1403

12156

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

225

1013

2.17

25.78

3.2

3.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

262

1257

2.03

25.41

2.4

e6/l

662.3

506.8

0.53

213

1073

(3042733) HLA Ab [Presence] in Serum

151

577

2.55

25.16

4.7

4.9

—

(21491868) Cryoglobulin [Mass/volume] in Serum

168

675

2.42

25.16

1.3

1.2

g/l

0.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2254

17438

1.28

25.08

3.8

2.7

ml/min/173m2

61.0

63.4

1.75

1035

7080

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

163

647

2.45

25.06

2.3

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

163

647

2.45

25.06

2.3

2.5

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

429

2433

1.72

24.63

3.6

3.2

nmol/l

9.8

8.9

0.10

413

2361

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

252

1206

2.04

24.62

2.4

2.5

e9/l

0.2

0.25

215

1068

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

235

1096

2.09

24.61

2.6

2.7

37.8

39.0

0.28

371

(3034770) Mitochondria Ab [Titer] in Serum

818

5406

1.48

24.60

1.2

titre

1060.0

1007.6

0.07

173

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

788

5172

1.49

24.52

1.2

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

296

1513

1.91

23.95

1.3

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

827

5509

1.47

23.90

2.0

mg/l

11.7

11.3

0.48

766

5079

(3035947) Staphylolysin Ab [Units/volume] in Serum

220

1024

2.09

23.20

1.1

iu/ml

5.2

4.2

0.27

(3017732) Neutrophils [#/volume] in Blood

1882

14382

1.29

23.03

3.7

2.9

e9/l

4.2

4.1

0.97

1395

10748

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

201

906

2.16

23.03

1.1

—

(3003694) ABO and Rh group [Type] in Blood

6282

54134

1.16

22.94

1.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

142

555

2.49

22.62

1.2

1.1

102.9

107.2

0.63

131

502

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

264

1327

1.94

22.49

2.2

1.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

152

618

2.40

22.24

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

218

1028

2.07

22.23

2.5

2.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

138

537

2.50

22.20

1.2

1.1

85.5

87.3

0.21

246

(21494755) Public health laboratory ask at order entry panel

1181

15290

0.74

22.13

1.3

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

351

1942

1.76

22.04

1.2

—

(40757373) Influenza virus identified in Isolate

118

427

2.69

22.00

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1645

12431

1.30

21.91

3.2

3.3

pmol/l

4.3

4.4

4.21

1435

10972

(3041354) Potassium [Moles/volume] in Venous blood

489

2963

1.61

21.82

2.9

2.4

mmol/l

4.0

4.1

1.52

484

2940

(3035285) Chloride [Moles/volume] in Venous blood

489

2963

1.61

21.82

2.9

2.4

mmol/l

105.8

105.5

0.68

484

2939

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

286

1492

1.87

21.79

1.5

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

260

1319

1.92

21.58

1.5

1.3

u/ml

1.7

1.2

0.40

134

649

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

184

823

2.18

21.53

2.8

2.7

—

(3051611) Lipemic interference index of Serum or Plasma

403

2333

1.69

21.52

4.6

3.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

467

2809

1.62

21.48

5.3

4.7

umol/l

351.8

358.0

0.34

394

2380

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

146

593

2.40

21.43

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

184

827

2.17

21.28

1.7

1.9

umol/l

118.9

119.4

0.01

432

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

223

1078

2.02

21.28

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

223

1078

2.02

21.28

1.6

1.4

—

(3019225) pH of Specimen

2787

22483

1.23

21.27

6.1

4.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

505

3108

1.59

21.13

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

280

1466

1.86

21.11

1.5

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

226

1101

2.00

21.10

3.5

3.7

—

(3008037) Lactate [Moles/volume] in Venous blood

759

5098

1.46

21.06

4.0

3.2

mmol/l

1.5

1.6

1.56

745

4990

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

263

3.14

21.03

2.1

2.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

480

2925

1.60

20.95

2.9

2.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

20913

196117

1.15

20.34

24.0

14.0

ml/min/173m2

76.8

78.0

10.73

18403

161882

(3024932) HLA-DR beta [Type]

140

572

2.38

20.31

1.1

—

(3014271) Vancomycin [Susceptibility]

252

1297

1.89

20.06

3.2

3.0

—

(40761535) Cells panel - Urine sediment

2332

18593

1.24

19.84

4.5

3.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

309

2.90

19.77

1.2

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

400

2365

1.65

19.75

2.4

1.9

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

619

4047

1.50

19.71

2.3

2.1

u/l

5713.4

4357.6

0.50

229

1530

(3024471) HLA-A [Type]

141

587

2.34

19.63

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2669

21617

1.22

19.51

2.0

1.7

1.6

1.5

3.70

2253

18710

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

105

384

2.66

19.24

1.3

1.2

111.2

109.0

0.19

368

(3038515) Glucose [Moles/volume] in Venous blood

717

4851

1.45

19.18

4.2

3.3

mmol/l

7.5

7.7

1.10

703

4758

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

542

3475

1.52

18.96

1.4

1.3

u/l

51.6

35.8

1.16

479

2983

(3021162) Amylase [Enzymatic activity/volume] in Specimen

317

2.82

18.89

2.6

2.7

u/l

966.1

1791.8

0.46

284

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

17119

158750

1.13

18.76

4.4

4.0

pmol/l

15.0

14.9

5.30

15620

143079

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

331

1888

1.71

18.74

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

789

5462

1.41

18.61

1.2

titre

102.8

135.8

0.99

482

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

601

3966

1.48

18.31

1.3

1.2

u/ml

43.2

44.7

0.08

400

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

455

2833

1.57

18.19

1.6

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

407

2471

1.61

18.11

1.2

u/ml

54.2

0.00

173

(3012565) Volume of 24 hour Urine

209

1047

1.94

18.10

2.3

2.1

1841.0

1933.0

0.68

190

907

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

127

524

2.36

18.09

7.5

5.4

70.0

69.9

0.01

105

409

(3000093) Morphology [Interpretation] in Blood Narrative

359

2114

1.66

18.05

1.2

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

550

3585

1.50

17.82

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

440

2735

1.57

17.73

1.6

1.4

—

(3006245) CD3-CD19+ cells/100 cells in Blood

143

628

2.22

17.61

2.0

9.5

10.2

0.24

130

575

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

441

2747

1.57

17.61

1.6

1.5

57.2

59.7

0.63

280

1721

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

256

2.96

17.52

1.3

1.4

67.5

75.4

1.30

210

(3024522) Salmonella sp identified in Specimen by Organism specific culture

444

2775

1.56

17.48

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

439

2738

1.57

17.44

1.6

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1212

9068

1.31

17.37

1.3

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

439

2742

1.56

17.33

1.6

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

263

2.92

17.31

4.3

5.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

344

2028

1.65

17.25

1.2

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

7703

68396

1.13

17.18

3.6

3.2

mmol/l

7.2

7.4

2.45

6374

56798

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

441

2766

1.56

17.10

1.6

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

701

4827

1.42

17.07

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

246

1325

1.81

17.04

2.2

1.8

—

(3044290) Cell count panel - Cerebral spinal fluid

589

3928

1.47

17.04

1.5

1.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

298

2.77

16.95

2.9

2.5

mg/l

101.8

71.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

175

845

2.02

16.87

1.3

1.4

63.8

63.3

0.06

139

686

(40768441) Liver Pathology biopsy report

262

1450

1.76

16.58

1.2

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

737

5149

1.40

16.53

1.4

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

276

2.82

16.45

6.1

5.1

ug/min

69.3

42.0

2.30

222

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

140

628

2.17

16.40

2.0

1.9

29.3

29.2

0.02

132

589

(3000330) Specific gravity of Urine by Test strip

1460

11278

1.27

16.34

4.6

3.6

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

153

715

2.08

16.14

1.3

1.4

2.5

2.7

0.06

130

592

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

20980

209285

0.88

16.08

5.2

5.1

mmol/l

2.7

6.60

19114

191286

(4281824)

365

2224

1.60

16.06

1.2

1.1

—

(3042517) Benzodiazepines panel - Urine

127

3.75

16.01

3.0

2.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

629

4307

1.43

15.84

1.5

1.3

u/l

12.3

11.2

1.04

517

3486

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

629

4310

1.43

15.78

1.5

1.4

pmol/l

241.5

152.3

1.84

612

4201

(3003181) Sodium [Moles/volume] in Urine

592

4018

1.44

15.65

1.4

mmol/l

63.2

62.1

0.25

458

3204

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

201

1045

1.87

15.64

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

201

1045

1.87

15.64

1.4

1.5

—

(3049717) Cytology report of Urine Cyto stain

1201

9108

1.29

15.57

2.6

2.8

—

(3014891) Appearance of Pleural fluid

329

2.60

15.53

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1228

15075

0.78

15.45

1.8

—

(3006576) Bicarbonate [Moles/volume] in Blood

163

793

2.00

15.44

5.6

6.3

mmol/l

25.0

24.9

0.08

152

711

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

752

9872

0.73

15.43

1.5

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

20321

202964

0.89

15.29

4.7

4.5

mmol/l

1.4

1.5

77.17

18519

185322

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

372

2.48

15.25

1.3

1.2

94.9

79.9

2.34

114

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

614

4218

1.42

15.20

1.6

1.4

e6/l

1450.9

2758.7

0.60

515

3451

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

308

2.62

14.89

12.3

10.7

mmol/l

5.6

5.3

0.32

308

(3012516) Albumin [Mass/volume] in Urine

7383

65830

1.12

14.87

3.6

3.2

mg/l

596.2

403.5

2.31

4800

41293

(3023383) Lactate [Moles/volume] in Pleural fluid

149

713

2.03

14.80

1.3

mmol/l

3.7

3.4

0.40

131

656

(3000060) B lymphocytes [#/volume] in Blood

103

425

2.36

14.77

1.9

2.0

e6/l

111.2

601.6

1.76

236

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

611

4217

1.42

14.75

1.5

1.3

e6/l

25.3

30.4

0.22

490

3265

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

20520

204720

0.89

14.70

4.7

4.6

mmol/l

4.6

13.23

18819

188048

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

210

2.96

14.46

1.2

ug/l

91.0

107.5

0.36

134

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

358

2233

1.56

14.32

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4840

42172

1.14

14.08

1.3

1.2

u/ml

1.4

1.7

1.91

1285

10936

(21494434) Karyotype in Bone marrow

307

1858

1.61

13.97

1.2

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

408

2641

1.51

13.79

1.8

1.7

—

(3011288) Drugs identified in Urine by Screen method

456

3020

1.47

13.77

5.3

3.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

373

2.40

13.75

1.2

87.7

68.7

2.72

111

(1761868) Lipid panel - Serum or Plasma

6482

68537

0.89

13.69

3.1

3.0

—

(3028707) Methadone [Presence] in Urine by Screen method

328

2027

1.58

13.68

4.2

2.7

—

(3045414) Leukocytes [Presence] in Urine

1228

9495

1.27

13.66

2.1

1.9

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

143

695

2.00

13.65

1.9

1.7

umol/l

2.0

0.11

135

648

(3020682) Albumin/Creatinine [Ratio] in Urine

7735

69439

1.11

13.51

4.4

3.9

mg/mmol

12.9

8.9

8.28

4950

43407

(3014148) Varicella zoster virus Ab [Titer] in Serum

333

2074

1.57

13.44

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

120

553

2.11

13.23

1.4

24.4

21.7

0.45

461

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

679

4861

1.36

13.22

1.4

1.3

mg/l

600.1

545.7

0.93

654

4608

(3003327) Ova and parasites identified in Stool by Light microscopy

859

6374

1.32

13.14

1.7

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

279

2.58

12.92

1.4

1.2

u/l

581.9

172.0

0.41

198

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

167

876

1.86

12.75

13.2

11.8

nmol/l

914.3

818.9

1.47

160

838

(3029634) Reagin Ab [Titer] in Serum by VDRL

366

2356

1.51

12.74

2.1

titre

1.8

7.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

384

2.30

12.48

1.2

—

(3045716) Anion gap in Serum or Plasma

180

975

1.80

12.40

2.6

2.4

mmol/l

8.5

9.1

1.78

129

712

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

265

1595

1.62

12.40

1.1

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

171

912

1.83

12.39

13.0

12.5

mmol/l

0.6

0.03

159

836

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

214

2.77

12.28

2.8

3.2

mg/l

1.1

1.2

0.10

161

(3000919) Neutrophils/100 leukocytes in Pleural fluid

131

643

1.98

12.22

1.3

1.4

22.4

20.5

0.33

122

573

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

401

2656

1.47

12.17

1.1

g/l

1.5

0.01

374

2388

(40761539) Cells [Type] in Urine sediment by Light microscopy

117

553

2.06

12.11

1.3

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.14

12.05

1.5

1.4

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

265

1609

1.60

11.98

1.2

u/ml

77.3

79.0

0.03

(3042010) Triglyceride [Moles/volume] in Pleural fluid

309

2.42

11.84

1.4

1.2

mmol/l

1.0

1.4

0.51

188

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

265

1614

1.60

11.83

1.2

u/ml

35.2

46.7

0.38

132

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

236

1398

1.64

11.79

3.7

3.3

nmol/l

148.5

140.1

0.11

230

1379

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

131

3.26

11.77

1.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

170

921

1.80

11.73

18.1

16.6

nmol/l

1538.0

2467.6

0.43

162

883

(3019150) Specific gravity of Urine by Refractometry

5215

46105

1.12

11.71

5.4

4.2

kg/l

1.0

0.41

796

7100

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

113

535

2.05

11.67

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

323

2069

1.52

11.56

1.7

1.5

31.7

28.9

0.62

194

1269

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

504

3516

1.40

11.55

1.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

200

2.77

11.49

2.1

1.6

umol/l

50.9

44.9

0.65

200

(3020393) Adenovirus Ag [Presence] in Stool

184

2.85

11.49

1.1

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

158

843

1.82

11.48

1.3

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

253

1537

1.60

11.44

1.2

u/ml

16.5

7.4

0.27

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

119

579

2.00

11.41

2.2

2.0

u/l

57.0

33.1

0.57

108

530

(3023487) Leukocytes [#/volume] in Peritoneal fluid

147

769

1.86

11.38

1.9

2.0

e6/l

2169.3

2773.1

0.15

538

(3047189) Immunofixation for 24 hour Urine

182

1018

1.74

11.28

1.9

1.7

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

210

1222

1.67

11.27

1.1

—

(40768443) Skin Pathology biopsy report

1225

9696

1.24

11.14

1.2

—

(3036603) Volume of Urine

234

1405

1.62

11.11

1.6

1760.4

1960.7

1.47

350

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

361

2388

1.47

11.07

1.2

u/l

60.6

60.3

0.02

264

1573

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

210

1229

1.66

11.04

1.1

—

(4198724)

117

574

1.98

10.98

2.5

2.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

439

3030

1.41

10.74

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

591

4283

1.35

10.72

1.3

1.2

mmol/l

3.8

0.05

548

4016

(3016750) Collection duration of Urine

217

1294

1.63

10.62

2.5

2.1

min

499.3

499.5

0.01

157

951

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

207

1221

1.65

10.58

1.9

u/field

2.7

2.6

0.07

145

849

(3017704) Immunofixation for Urine

208

1233

1.64

10.43

1.7

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

112

552

1.97

10.40

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

650

4799

1.32

10.40

2.5

2.2

—

(3038026) Centromere Ab [Units/volume] in Serum

265

1666

1.55

10.39

1.3

1.2

u/ml

64.0

51.2

0.21

(3023511) Choriogonadotropin [Units/volume] in Urine

299

1930

1.51

10.38

1.5

1.3

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

335

2.26

10.35

1.5

1.6

ug/l

102.4

113.4

0.45

277

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

122

3.19

10.33

1.1

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

449

2.08

10.30

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

244

1511

1.57

10.23

1.6

1.4

promille

1.2

1.3

0.56

188

1143

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

225

1367

1.60

10.23

1.3

1.2

u/l

99.0

91.5

0.60

202

1186

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

393

2686

1.43

10.19

1.3

—

(3044007) Cell count panel - Peritoneal fluid

119

605

1.91

10.11

1.8

1.9

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

181

1046

1.68

10.03

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

454

2.06

10.01

1.2

1.1

—

(3000012) Reticulocyte production index

211

1270

1.62

9.98

1.6

1.5

—

(3022621) pH of Urine by Test strip

1723

14252

1.19

9.93

3.6

3.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

223

2.53

9.84

8.4

7.2

umol/l

0.4

0.19

197

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

383

2626

1.42

9.77

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

801

6134

1.28

9.75

5.6

4.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

218

1331

1.59

9.74

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

193

1145

1.64

9.69

1.2

u/l

209.6

340.3

2.20

181

1055

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

218

1333

1.59

9.68

1.3

1.2

u/l

30.9

25.2

0.80

195

1128

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

289

1882

1.50

9.65

2.2

2.1

u/field

2.6

2.3

0.18

118

748

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

464

3296

1.37

9.62

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1497

12265

1.20

9.62

1.2

iu/ml

115.7

141.9

2.00

494

4567

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

322

2145

1.46

9.60

1.2

1.1

iu/ml

2.5

2.0

—

(3011985) Renin [Units/volume] in Plasma

401

2784

1.40

9.54

1.6

1.4

mu/l

57.8

59.0

0.05

359

2455

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

128

681

1.83

9.48

1.8

e6/l

19755.0

9621.7

0.63

375

(3044927) Protein electrophoresis panel - Urine

347

2353

1.44

9.43

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

650

4873

1.30

9.35

1.7

mu/l

311.2

297.4

0.51

594

4420

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

319

2.22

9.34

1.4

1.2

ng/l

153.5

363.3

0.38

210

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

181

1068

1.65

9.30

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

259

2.36

9.28

3.6

2.9

umol/l

39.6

40.0

0.05

213

(40768795) Lymph node Pathology biopsy report

313

2089

1.46

9.26

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

418

2939

1.39

9.25

1.3

nmol/l

0.2

0.3

1.38

209

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

449

2.01

9.21

1.2

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

202

2.55

9.18

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

417

2939

1.38

9.10

1.3

nmol/l

0.6

1.7

1.18

403

2814

(3052592) Norovirus Ag [Presence] in Stool

454

1.99

8.95

1.3

—

(3036180) Methadone [Presence] in Urine

7.43

8.93

2.2

2.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

371

2575

1.40

8.88

1.3

1.2

—

(3002619) Bacteria identified in Specimen by Culture

443

2.00

8.83

1.4

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

346

2.14

8.81

1.7

1.6

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

279

2.26

8.71

1.3

1.4

nmol/l

7.6

241957.5

1.67

236

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

128

700

1.78

8.70

1.6

1.4

iu/ml

828925.0

2164314.3

—

(3042951) Complement C1q Ab [Units/volume] in Serum

3.48

8.63

1.1

1.2

u/ml

35.0

13.8

—

(3008295) Osmolality of Serum or Plasma

309

2087

1.44

8.63

1.4

1.3

mosm/kgh2o

280.4

277.3

1.30

244

1580

(3034891) Synovial lining cells/100 cells in Synovial fluid

175

1045

1.63

8.62

1.5

2.7

3.8

0.85

226

(3034274) Bile acid [Moles/volume] in Serum --fasting

240

1542

1.52

8.61

1.9

1.8

umol/l

8.2

9.8

0.49

190

1109

(3002331) Protein [Mass/volume] in Peritoneal fluid

474

1.95

8.61

1.2

1.4

g/l

29.9

41.3

0.41

354

(40761511) CBC panel - Blood by Automated count

22549

215019

1.11

8.54

23.9

14.1

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

106

3.12

8.53

1.5

1.6

mg/l

0.5

1.4

0.99

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

106

3.12

8.53

1.5

1.6

mg/l

4.9

4.2

0.17

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

106

3.12

8.53

1.5

1.6

mg/l

2.1

1.8

0.17

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

106

3.12

8.53

1.5

1.6

mg/l

2.7

2.5

0.11

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

106

3.12

8.53

1.5

1.6

mg/l

1.2

3.2

1.81

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

106

3.12

8.53

1.5

1.6

mg/l

1.0

1.1

0.06

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

106

3.12

8.53

1.5

1.6

mg/l

1.0

2.0

1.34

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

106

3.12

8.53

1.5

1.6

mg/l

2.8

2.0

0.23

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

190

1162

1.59

8.50

1.7

1.4

u/l

6.1

6.0

0.09

170

968

(3024263) Appearance of Synovial fluid

189

1155

1.59

8.48

1.7

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

483

3531

1.33

8.37

3.3

2.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

5.16

8.32

1.7

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

134

2.83

8.28

2.0

2.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

261

2.27

8.25

2.1

2.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1385

11433

1.19

8.21

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

363

2547

1.39

8.19

1.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

161

955

1.64

8.17

1.4

1.6

ug/l

7.3

9.2

1.36

148

864

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

219

1400

1.52

8.08

1.7

1.6

u/l

4.7

6.5

1.01

128

651

(3033799) Differential panel - Peritoneal fluid

121

667

1.76

8.05

2.0

1.9

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.85

7.93

11.5

11.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

367

2595

1.38

7.92

1.4

1.3

pmol/l

298.8

281.2

0.35

280

1992

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

111

2.98

7.91

1.5

1.6

mg/l

1.6

2.3

0.36

(3016018) Differential panel - Cerebral spinal fluid

302

2070

1.42

7.83

1.5

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

112

609

1.79

7.81

2.9

3.0

—

(3046861) Legionella sp Ag [Presence] in Urine

112

2.95

7.80

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.86

7.79

1.7

1.4

—

(3007463) Buprenorphine [Presence] in Urine

4.86

7.79

6.5

7.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

471

1.90

7.77

2.3

—

(3028433) Virus identified in Specimen by Culture

122

682

1.74

7.75

1.2

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3345

29475

1.12

7.71

1.5

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

514

1.85

7.69

2.2

1.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

439

1.93

7.68

7.6

7.9

—

(4015189)

114

628

1.77

7.62

2.6

2.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

20102

190939

1.08

7.61

5.3

4.8

mu/l

2.0

2.1

0.30

18470

173216

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

19788

196144

0.92

7.60

4.2

4.1

mmol/l

1.4

1.3

51.27

17895

177727

(3004775) Volume in Urine collected for unspecified duration

270

1824

1.44

7.59

2.4

2.2

737.7

663.8

1.44

187

1210

(3001686) Cold agglutinin [Titer] in Serum or Plasma

381

1.99

7.57

1.4

1.3

titre

84.3

209.2

0.90

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

247

2.24

7.52

2.2

2.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

266

2.19

7.50

1.3

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

188

1183

1.55

7.49

2.2

2.1

umol/l

17.0

25.9

0.88

109

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

295

2032

1.41

7.46

1.8

titre

2301.5

2130.8

0.05

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

385

2775

1.35

7.40

1.1

au/ml

14.0

11.6

0.21

144

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

138

2.67

7.31

2.0

2.1

mg/l

17.2

21.0

0.97

126

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

106

2.93

7.29

1.8

1.3

mmol/l

23.8

22.6

0.86

(3032352) Blasts [#/volume] in Cerebral spinal fluid

190

2.40

7.27

3.0

1.6

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.60

7.24

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

864

6911

1.22

7.23

1.4

1.3

iu/l

30.9

31.7

0.29

728

5981

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

526

1.81

7.18

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

123

2.76

7.17

1.1

u/field

1.2

0.10

(44816559) Phosphatidylethanol [Mass/volume] in Blood

450

3338

1.31

7.12

1.4

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

113

2.84

7.09

5.4

4.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.26

7.09

3.1

3.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

522

1.81

7.05

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

100

544

1.79

7.02

1.3

1.4

g/l

15.7

13.3

1.64

415

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

256

1742

1.43

6.97

1.7

1.6

u/ml

25.9

25.7

0.01

365

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

165

1027

1.56

6.94

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

114

647

1.71

6.91

1.3

1.2

g/l

0.3

2.14

100

518

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

164

1021

1.56

6.90

2.7

2.4

u/l

221.9

206.1

1.15

164

1011

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

540

1.78

6.89

1.2

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1702

14481

1.15

6.89

2.4

2.1

nmol/l

10.9

12.3

9.85

1468

12691

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

527

1.79

6.85

1.6

ug/l

0.3

0.4

0.34

329

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

520

1.79

6.85

7.7

8.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

423

1.88

6.83

1.3

1.2

mmol/l

2.0

1.5

2.89

253

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

397

2913

1.33

6.81

2.3

2.1

mg/l

30.5

26.4

0.56

107

764

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

150

918

1.59

6.79

1.5

1.2

51.2

62.1

0.65

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

107

600

1.73

6.78

1.3

1.2

114.1

111.4

0.44

526

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

203

2.30

6.75

1.1

1.0

—

(36660697) Celiac disease serology panel - Serum

1788

15288

1.14

6.74

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

162

2.46

6.69

1.1

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

338

1.98

6.69

3.1

2.8

—

(44786800) Granulocytes/100 leukocytes in Body fluid

306

2.03

6.64

1.2

1.4

24.3

25.0

0.06

240

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

152

2.49

6.56

1.6

1.2

ml/s/173m2

0.7

1.0

0.86

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

102

2.86

6.55

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

227

1533

1.44

6.48

1.4

1.3

mmol/l

2.3

2.2

0.84

211

1414

(3016038) Potassium [Moles/volume] in Urine

218

1462

1.45

6.45

1.2

1.1

mmol/l

33.6

35.2

0.40

186

1228

(3051593) INR in Capillary blood by Coagulation assay

181

1170

1.50

6.44

12.2

10.6

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

370

1.92

6.43

1.1

pmol/l

3.2

8.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1450

12258

1.16

6.43

2.6

2.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

248

1706

1.41

6.40

1.1

—

(3023410) Appearance of Cerebral spinal fluid

268

1871

1.39

6.35

1.6

1.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

23069

220845

1.09

6.20

30.3

17.4

umol/l

83.6

79.2

41.04

23064

220736

(3016244) Insulin [Units/volume] in Serum or Plasma

147

921

1.55

6.07

3.2

mu/l

36.8

26.0

1.37

133

865

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

497

1.76

6.07

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1040

8610

1.18

6.05

1.1

titre

164.8

210.1

0.35

207

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

294

2105

1.36

6.00

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

164

1058

1.51

5.94

1.5

—

(3016879) Cocaine [Presence] in Urine

552

4306

1.25

5.93

3.2

2.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

515

1.74

5.93

1.3

1.2

nmol/l

120.5

130.7

0.25

372

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

3.55

5.89

1.0

1.1

u/field

1.2

0.06

(3028300) Cannabinoids [Presence] in Urine

594

4677

1.24

5.87

3.1

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

589

4636

1.24

5.84

3.1

2.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

503

1.74

5.84

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

610

4821

1.23

5.82

1.7

1.8

iu/l

4.7

12.8

0.89

198

1673

(3003129) Base excess in Capillary blood by calculation

569

1.69

5.81

1.7

1.8

mmol/l

0.6

0.02

538

(3008898) HLA-B27 [Presence]

697

5591

1.22

5.76

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1592

13665

1.14

5.70

2.4

au/ml

23.0

27.4

0.57

696

(3009542) Hematocrit [Volume Fraction] of Blood

19499

185622

1.07

5.70

27.6

16.0

38.7

39.4

19.24

13115

126933

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

521

4058

1.25

5.69

2.3

1.7

nmol/l

1.0

0.8

3.87

445

3369

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

136

852

1.55

5.65

1.7

1.6

nmol/l

4.0

6.9

0.48

115

719

(3009871) Measles virus Ab [Titer] in Serum

104

611

1.65

5.64

1.6

1.7

—

(3034988) Calcium [Moles/volume] in Capillary blood

382

1.83

5.58

1.8

1.7

mmol/l

1.2

0.02

365

(3027008) Opiates [Presence] in Urine

589

4664

1.23

5.55

3.1

1.9

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

504

1.72

5.54

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

468

1.74

5.53

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

187

1258

1.45

5.52

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

719

8339

0.83

5.46

1.6

1.7

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.05

5.43

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

223

1554

1.40

5.42

3.2

2.5

—

(40765096) Chromosome analysis panel by Banding

102

603

1.64

5.41

1.2

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

358

1.85

5.41

1.4

1.5

9.6

11.5

0.29

174

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

903

7469

1.18

5.36

1.7

1.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

503

1.70

5.31

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

273

1.96

5.23

2.1

2.6

pmol/l

115.8

69.6

0.55

237

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1604

13867

1.13

5.16

1.9

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

254

1825

1.35

5.14

1.3

nmol/l

1.6

1.4

1.58

231

1651

(3047185) IgG [Mass/volume] in Urine

3.61

5.11

1.1

—

38.7

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

130

827

1.53

5.09

2.2

ug/l

79.0

241.8

0.85

121

789

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

129

2.41

5.09

1.1

—

(3027944) Amphetamines [Presence] in Urine

574

4579

1.22

5.07

2.9

1.9

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

124

2.43

5.01

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

598

1.61

4.87

2.0

1.7

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

206

1446

1.39

4.85

1.3

titre

53.6

62.6

0.28

126

(3024869) Neuronal Ab [Presence] in Serum

394

1.75

4.80

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

590

4755

1.21

4.73

4.9

3.5

mg/l

29.4

27.8

0.51

398

3046

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

197

1382

1.39

4.67

1.2

1.1

mg/l

44.6

43.3

0.12

173

1147

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

162

1099

1.43

4.65

1.1

iu/ml

8.7

9.0

0.06

249

(3026480) Teichoate Ab [Titer] in Serum

192

2.07

4.61

1.1

1.0

—

2.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

210

1493

1.37

4.60

1.3

titre

483.3

422.8

0.10

121

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.69

4.59

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

106

2.47

4.57

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1435

12423

1.13

4.56

1.8

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.56

4.52

1.1

37.7

36.5

0.91

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.56

4.52

1.1

20.3

21.5

0.59

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.56

4.52

1.0

1.1

7.8

8.7

0.94

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

149

2.22

4.51

1.3

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

109

687

1.54

4.51

1.2

1.3

ug/l

428.0

278.4

0.27

379

(3006969) Lambda light chains [Mass/volume] in Urine

3.17

4.50

1.1

1.0

g/l

0.1

0.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

119

2.37

4.47

5.7

8.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

613

1.57

4.43

1.4

1.2

37.5

20.4

1.10

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

218

1571

1.35

4.40

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

277

1.86

4.39

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

277

1.86

4.39

1.3

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1433

12435

1.13

4.39

1.3

au/ml

45.3

50.3

0.26

534

(40760409) HLA-A [Type] by High resolution

3.01

4.38

1.1

1.0

—

(40763590) HLA-DQ beta [Type]

3.01

4.38

1.1

1.0

—

(40760410) HLA-B [Type] by High resolution

3.01

4.38

1.1

1.0

—

(46236302) HLA-C [Type] by High resolution typing

3.01

4.38

1.1

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

216

1.98

4.38

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

147

992

1.44

4.37

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

320

1.79

4.35

1.7

1.8

pmol/l

61.9

52.9

0.16

263

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

126

828

1.48

4.30

2.1

2.3

umol/l

55.4

54.8

0.06

666

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

437

1.67

4.30

3.1

2.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

109

695

1.52

4.30

1.3

g/l

39.8

39.7

0.01

367

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

365

1.73

4.26

5.8

4.8

u/l

34.2

62.5

1.68

141

(3030313) Adrenal Ab [Titer] in Serum

128

2.28

4.26

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

232

1.93

4.25

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

116

2.34

4.24

1.3

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

610

4987

1.19

4.24

3.3

3.1

nmol/l

0.8

1.31

462

3852

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.57

4.21

1.0

u/ml

0.3

0.1

0.46

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

240

1.90

4.19

1.1

u/l

21.4

18.5

0.36

163

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

186

1322

1.37

4.13

1.1

mg/l

312.8

281.0

0.46

167

1158

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

228

1.92

4.11

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

277

1.82

4.08

1.3

1.2

—

(3025315) Body weight

182

2.03

4.07

4.6

4.7

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

292

1.80

4.04

1.2

—

(3013862) HLA-DP [Type]

2.87

4.04

1.1

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

183

2.02

4.01

3.8

2.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

300

1.78

4.01

1.5

1.6

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.05

3.98

1.1

1.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

23017

221037

1.07

3.93

16.3

10.4

u/l

26.2

25.8

1.77

22434

212295

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

509

1.58

3.92

1.3

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

279

2125

1.28

3.83

1.5

1.4

e6/l

202342.6

120426.7

0.84

187

1474

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

536

1.56

3.80

2.2

1.9

mg/l

8.3

9.2

0.73

431

(1002224) Polysomnography panel

865

7344

1.15

3.77

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

215

1.90

3.76

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

250

1.83

3.74

1.5

1.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.35

3.70

1.5

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

126

856

1.43

3.68

3.2

2.4

—

(3048879) Bone marrow aspiration report

104

681

1.48

3.68

1.8

1.7

—

(40758292) HTLV I+II Ab panel - Serum

280

1.77

3.67

1.6

1.4

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.56

3.66

2.5

1.4

ug/l

90.5

137.0

0.97

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

6.47

3.59

2.3

1.3

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.52

3.57

1.1

1.0

u/ml

0.1

0.0

0.59

(3006442) Creatine [Moles/volume] in Serum or Plasma

194

1425

1.32

3.53

1.7

1.6

umol/l

72.0

71.3

—

101

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

150

1061

1.37

3.50

1.5

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

463

1.57

3.49

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.33

3.48

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

152

1079

1.37

3.47

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

446

5144

0.84

3.35

1.4

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

356

1.64

3.30

1.2

—

(3028468) Fragments [Presence] in Blood by Light microscopy

6.80

3.29

3.1

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.62

3.28

1.3

nmol/l

585.6

482.5

0.26

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

105

2.22

3.28

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

558

1.50

3.23

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

160

1160

1.34

3.22

1.2

1.1

u/l

31.0

26.1

0.49

124

879

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

160

1160

1.34

3.22

1.2

1.1

u/l

90.5

88.2

0.13

132

912

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

285

1.70

3.20

2.3

1.9

umol/l

16.3

16.7

0.09

285

(3001186) Copper [Moles/volume] in Serum or Plasma

420

1.57

3.19

1.5

1.2

umol/l

17.3

16.7

0.52

371

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

152

1.98

3.18

1.0

1.1

u/l

12.6

10.2

0.17

152

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

273

2130

1.25

3.14

1.4

nmol/l

0.4

0.3

0.13

189

1591

(3035933) Granulocytes/100 leukocytes in Blood

422

1.57

3.13

1.7

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

114

2.13

3.10

1.6

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

912

7882

1.13

3.10

1.1

u/ml

16.9

7.5

0.25

112

(3027035) Albumin [Mass/time] in 24 hour Urine

195

1.84

3.09

1.8

1.3

mg/24h

24.6

576.8

—

(3050794) Legionella sp Ab [Presence] in Serum

168

1.91

3.06

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

217

1655

1.27

3.04

1.2

titre

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.47

3.04

1.6

2.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

109

751

1.41

3.02

3.7

2.9

umol/l

29.0

28.4

0.24

570

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

121

849

1.39

3.02

1.1

—

(3045424) Erythrocytes [Presence] in Urine

442

3633

1.18

3.01

1.6

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

176

1.88

3.00

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

192

1445

1.29

2.99

1.1

1.0

mg/l

304.7

288.3

2.32

169

1292

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

143

1.97

2.95

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

5.66

2.95

1.0

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

105

723

1.41

2.93

1.4

1.3

umol/l

3.8

3.9

0.12

659

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

126

895

1.37

2.93

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

430

1.54

2.91

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

138

996

1.35

2.91

1.2

1.3

—

(4027681)

141

1021

1.34

2.91

1.3

—

(3017400) Magnesium [Moles/volume] in Urine

3.14

2.90

1.1

1.0

mmol/l

2.9

2.3

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.31

2.86

1.1

u/field

1.0

1.4

0.42

(42529582) MDA5 Ab [Presence] in Serum by Line blot

511

1.48

2.84

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

511

1.48

2.84

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

511

1.48

2.84

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

511

1.48

2.84

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

123

876

1.36

2.83

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

156

1152

1.32

2.82

1.1

nmol/l

4.5

6.9

0.41

235

(3010838) Calcium [Moles/time] in 24 hour Urine

147

1077

1.33

2.81

1.6

mmol/24h

3.7

5.9

1.74

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

2.56

2.79

1.0

u/ml

0.1

0.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

210

1.76

2.76

1.1

u/ml

0.0

0.5

1.43

134

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

4.31

2.71

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

100

694

1.40

2.70

1.3

1.4

pmol/l

15.0

15.7

0.77

574

(3033942) Copper [Moles/time] in 24 hour Urine

2.51

2.70

1.4

1.1

umol/24h

1.5

0.5

—

(4034850)

812

7037

1.12

2.69

14.8

10.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

220

1.72

2.65

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

600

1.42

2.64

3.1

2.3

nmol/l

145.0

150.2

0.20

521

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

562

1.43

2.59

1.5

2.3

ug/l

0.9

1.0

0.26

532

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

221

1727

1.24

2.58

1.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

293

2359

1.21

2.57

1.5

1.3

u/l

28.8

31.3

0.67

259

1909

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.89

2.55

1.4

1.3

e6/l

11.8

38.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

529

4477

1.15

2.55

1.3

miu/ml

212.4

222.5

0.23

174

1927

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2748

28223

0.94

2.54

1.4

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.43

2.53

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

166

1.81

2.52

1.2

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

102

722

1.37

2.49

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.15

2.45

1.6

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

23472

229451

0.95

2.44

38.4

21.9

g/l

131.0

134.6

227.97

23214

225591

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.18

2.42

1.1

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

403

1.49

2.40

1.3

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

467

1.46

2.39

1.2

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

357

1.52

2.38

6.3

7.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

358

2959

1.18

2.37

1.1

iu/ml

53.5

4650.6

0.66

599

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

20706

202987

0.96

2.36

5.1

4.8

mmol/l

6.1

6.0

12.13

18834

183617

(3026361) Erythrocytes [#/volume] in Blood

23471

229399

0.95

2.33

38.2

21.8

e12/l

4.4

4.5

121.07

22935

221887

(3010813) Leukocytes [#/volume] in Blood

23475

229432

0.95

2.32

38.2

21.8

e9/l

7.0

6.8

33.30

22951

221941

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

122

1.91

2.30

1.1

1.2

—

(3024731) MCV [Entitic volume]

23471

229385

0.95

2.30

38.1

21.7

91.6

91.3

16.17

23196

225526

(43055514) Macroprolactin [Presence] in Serum or Plasma

337

1.53

2.29

1.5

1.6

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

179

1.74

2.28

2.0

2.1

mmol/l

0.5

1.0

1.50

112

(3027923) C peptide [Moles/volume] in Serum or Plasma

151

1148

1.28

2.27

1.4

nmol/l

1.4

1.2

0.77

114

888

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

231

1.64

2.26

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

129

962

1.30

2.25

1.1

u/l

1.0

1.1

0.54

458

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

168

1296

1.26

2.25

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

137

1.84

2.25

1.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

202

1.68

2.24

1.2

1.1

u/ml

0.1

3.0

0.89

(3039443) Prostate specific Ag panel - Serum or Plasma

308

3523

0.85

2.23

1.6

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.28

2.23

1.1

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

293

1.56

2.22

1.1

—

(3035941) MCH [Entitic mass]

23471

229354

0.95

2.22

38.0

21.7

30.2

30.4

17.13

23197

225500

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

427

3602

1.15

2.20

2.1

1.9

pmol/l

184.1

196.0

1.67

401

3377

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.77

2.18

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

477

1.43

2.17

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

445

1.44

2.16

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

429

1.45

2.16

1.3

1.2

mu/l

115.5

60.9

0.89

311

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

2.48

2.13

1.0

u/ml

0.0

0.1

—

(3007916) DNA double strand Ab [Titer] in Serum

258

1.58

2.13

1.7

1.3

titre

293.3

105.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

169

1.72

2.11

1.9

1.7

mg/l

1.7

1.6

0.15

140

(44813793)

169

1317

1.25

2.10

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

298

1.53

2.08

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

148

1.77

2.08

2.4

1.6

0.9

0.8

0.13

116

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

165

1285

1.25

2.07

1.2

—

(3007461) Platelets [#/volume] in Blood

23468

229253

0.95

2.05

38.2

21.8

e9/l

248.9

247.9

1.33

22998

222571

(3032743) Legionella sp IgG Ab [Presence] in Serum

135

1.80

2.03

1.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.82

1.99

2.6

4.8

—

(3034614) HLA Ag [Interpretation]

2.82

1.99

1.3

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

462

1.41

1.97

1.2

1.1

umol/24h

0.7

0.8

0.42

217

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

511

1.39

1.97

2.4

2.5

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.99

1.95

1.1

1.0

—

(3017509) Phencyclidine [Presence] in Urine

137

1.77

1.94

2.2

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.94

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

819

0.71

1.92

1.5

1.4

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

138

1.76

1.90

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.04

1.88

1.4

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

2.04

1.88

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

394

1.43

1.87

2.3

1.7

ug/l

3.4

2.9

0.16

230

(3026470) Cobalt [Mass/volume] in Blood

186

1488

1.21

1.85

2.0

ug/l

3.8

0.00

159

1315

(3024316) Viscosity of Plasma

1.90

1.84

2.3

1.7

mpas

1.8

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

174

1385

1.22

1.82

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

162

1.68

1.82

1.1

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

369

3131

1.15

1.82

1.3

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.12

1.81

1.9

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.92

1.80

2.6

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

3.43

1.78

1.2

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

390

4297

0.88

1.78

1.6

1.5

—

(3025577) Chromium [Mass/volume] in Blood

181

1453

1.21

1.76

2.0

ug/l

2.4

2.3

0.12

139

1213

(4024509)

260

2156

1.17

1.76

1.7

1.6

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

482

1.37

1.74

2.3

2.4

mmol/l

6.7

7.6

2.33

306

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.95

1.74

1.1

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

122

1482

0.80

1.73

1.4

1.5

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

684

1.31

1.73

1.7

1.4

59.2

56.5

0.30

582

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

558

1.34

1.72

1.4

1.3

41.7

35.8

0.69

367

(3027231) Wheat IgE Ab [Units/volume] in Serum

289

1.48

1.71

1.1

1.0

—

0.8

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

559

1.34

1.71

1.4

1.6

iu/ml

—

558.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

133

1039

1.24

1.69

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

167

1338

1.21

1.67

1.6

2.0

nmol/l

17.5

16.7

0.59

158

1250

(3044416) Complement C4 [Mass/volume] in Pleural fluid

115

1.77

1.67

1.3

1.2

g/l

0.1

0.23

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.73

1.67

2.6

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

197

1.58

1.66

1.0

1.1

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.94

1.66

1.1

1.0

mmol/l

5.2

5.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

2.59

1.65

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

152

1.66

1.65

1.0

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

300

1.46

1.64

2.5

2.7

u/field

0.7

0.5

0.62

300

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

123

1.74

1.64

1.1

—

(3018133) Calcium [Moles/volume] in Urine

261

1.49

1.62

1.8

1.6

mmol/l

2.7

0.06

230

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

191

1.58

1.61

1.0

1.1

—

(40768793) Breast Pathology biopsy report

526

4603

1.11

1.61

1.3

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.92

1.61

1.1

1.0

u/ml

34.5

37.9

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.92

1.61

1.1

1.0

u/ml

16.9

27.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

560

5999

0.90

1.60

1.8

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

569

5003

1.11

1.59

1.9

1.7

nmol/l

40.3

43.1

2.42

558

4828

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5924

59062

0.97

1.59

4.3

4.4

21.5

22.1

2.16

2890

29599

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

287

1.45

1.57

1.3

1.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

104

799

1.26

1.55

1.1

ng/l

884.7

660.4

0.13

189

(3001729) Color of Synovial fluid

178

1.58

1.54

2.2

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

625

5532

1.10

1.54

2.7

2.3

ug/min

138.6

107.2

0.74

386

3198

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.43

1.53

1.0

1.1

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.91

1.53

1.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.97

1.52

1.1

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

283

2394

1.15

1.52

1.1

u/ml

3.9

3.8

0.05

1038

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

537

1.32

1.51

2.8

3.0

mg/l

7.7

0.02

437

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

596

6343

0.91

1.51

1.9

1.7

mg/l

4.5

3.5

1.30

471

4496

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

164

1.60

1.51

1.1

1.2

31.3

23.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

134

1.67

1.50

1.6

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

162

1312

1.20

1.49

1.7

1.4

ug/l

2.5

4.1

2.03

120

1063

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

177

2033

0.84

1.47

1.5

—

(3020491) Glucose [Moles/volume] in Blood

190

1563

1.18

1.47

2.3

1.9

mmol/l

7.5

7.0

1.16

141

1087

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

379

3280

1.12

1.45

1.7

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

577

5109

1.10

1.44

1.1

u/ml

3.2

8.0

4.06

554

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

114

1.70

1.42

1.1

u/l

3.2

3.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

442

1.34

1.42

2.0

1.6

au/ml

189.9

113.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

351

1.38

1.41

1.1

—

(4146454)

229

2566

0.87

1.41

2.4

2.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

249

2766

0.87

1.36

1.5

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

138

1112

1.21

1.36

2.2

ug/min

115.6

112.2

0.02

252

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

116

1.67

1.35

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

101

790

1.24

1.33

1.1

miu/ml

1529.2

1560.1

0.10

101

790

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

298

1.40

1.32

1.2

1.3

59.3

51.7

0.42

133

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.13

1.32

1.3

1.1

1.6

2.6

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

102

1.71

1.32

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

214

2391

0.87

1.29

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

190

1585

1.16

1.28

1.3

1.2

mmol/l

12.1

12.0

0.08

455

(3002523) Influenza virus A Ag [Presence] in Specimen

283

2431

1.13

1.26

1.2

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

503

1.29

1.25

2.4

au/ml

206.1

157.5

0.26

(4211845)

142

1161

1.19

1.23

4.0

3.3

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.16

1.21

1.1

—

(3006462) Nitrate [Presence] in Urine

130

1057

1.19

1.20

4.1

3.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

282

2436

1.12

1.17

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

699

1.24

1.17

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

273

1.39

1.16

2.7

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.73

1.16

1.0

pmol/l

265.7

174.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

250

1.40

1.13

1.6

1.7

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

607

1.25

1.12

2.6

1.7

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

194

1.45

1.11

2.6

2.1

72.1

59.0

1.14

123

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.99

1.11

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.43

1.11

1.2

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.43

1.11

1.4

2.5

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

2.43

1.11

1.0

1.1

nmol/l

297.6

290.3

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.74

1.10

1.0

1.1

u/ml

1.2

0.5

—

(3016330) Potassium [Moles/time] in 24 hour Urine

293

1.36

1.10

1.3

1.2

—

84.7

—

(3009015) Lactate [Moles/volume] in Synovial fluid

253

1.38

1.07

1.2

1.3

mmol/l

5.9

6.3

0.11

120

(3004446) Plasmodium sp identified in Blood by Light microscopy

164

1.48

1.06

2.2

2.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

262

1.37

1.05

1.0

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.12

1.05

1.0

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.12

1.05

1.1

—

(36303858) Crystals [Presence] in Urine

2.12

1.05

1.0

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.79

1.04

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

305

1.34

1.03

1.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

202

2221

0.88

1.02

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5579

55285

0.97

1.01

1.7

1.6

mmol/l

1.5

1.3

17.93

4630

46011

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1031

9487

1.06

1.00

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

202

2216

0.88

0.99

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

224

1.39

0.99

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

151

1.48

0.98

1.2

1.5

28.4

38.1

0.48

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

193

1651

1.14

0.98

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

564

5879

0.93

0.97

1.4

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.78

0.95

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

683

1.21

0.95

1.2

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

204

2227

0.89

0.94

1.4

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.62

0.94

1.5

1.6

u/l

0.9

0.1

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

2.24

0.93

1.2

1.0

u/ml

0.0

0.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

204

2225

0.89

0.93

1.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

195

1.39

0.90

7.9

5.4

—

(3049242) von Willebrand panel - Platelet poor plasma

1.75

0.90

1.6

1.9

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.08

0.89

1.7

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

254

1.34

0.89

12.7

9.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2723

27200

0.97

0.87

4.5

4.7

31.6

32.7

6.63

1948

18143

(3028717) Thiamine [Mass/volume] in Blood

205

1.37

0.87

1.2

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

197

1.38

0.86

1.1

1.0

u/ml

0.8

0.01

144

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

156

1.43

0.86

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

116

1.51

0.86

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

172

1882

0.89

0.85

1.5

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.81

0.85

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

507

1.23

0.84

1.1

1.2

pmol/l

348.8

287.5

0.50

362

(3013762) Body weight Measured

1.76

0.84

1.4

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

291

1.30

0.83

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

166

1817

0.89

0.83

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

168

1833

0.89

0.81

1.9

1.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7740

74059

1.02

0.79

5.0

5.1

ug/l

3.5

3.7

0.22

6844

66076

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

134

1480

0.88

0.79

1.0

ng/l

37.3

43.1

1.17

1000

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

0.00

0.78

0.0

1.0

—

0.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

327

2923

1.09

0.78

1.1

u/ml

1.2

1.3

0.05

140

1104

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

201

1.35

0.78

1.2

1.1

iu/ml

9.5

19.6

0.94

(44806420)

690

1.18

0.78

2.0

2.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

193

1.36

0.78

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

193

1.36

0.78

1.3

1.2

nmol/l

0.2

0.3

0.02

125

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

204

1784

1.11

0.77

4.0

5.0

u/ml

128.7

107.5

0.14

533

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

134

1477

0.88

0.77

1.0

ng/l

764.2

715.8

0.67

985

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.76

0.0

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

293

2612

1.09

0.76

1.1

u/ml

3.3

4.4

0.88

156

1236

(3006270) Folate [Moles/volume] in Blood

220

1935

1.10

0.75

1.2

nmol/l

306.4

348.7

1.85

174

1566

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.54

0.75

11.9

8.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

168

1823

0.89

0.75

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

121

1340

0.88

0.75

1.4

1.3

pmol/l

307.4

70.5

0.66

444

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

418

1.23

0.75

1.1

1.0

u/ml

22.5

9.1

—

(40762814) Titanium [Mass/volume] in Blood

427

1.23

0.75

2.3

ug/l

3.2

3.5

0.36

157

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.65

0.73

1.2

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

134

1471

0.88

0.73

1.0

ng/l

299.9

323.8

0.52

1015

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.54

0.70

1.0

1.1

nmol/l

306.2

244.3

0.47

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

153

0.63

0.69

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

107

1.45

0.67

4.0

3.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

779

7215

1.05

0.67

1.9

1.8

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

216

1.30

0.66

1.3

1.1

umol/24h

1.9

1.7

0.40

216

(3010726) Horse dander IgE Ab [Units/volume] in Serum

259

2315

1.09

0.66

1.1

u/ml

1.2

1.5

0.34

535

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

628

0.83

0.65

1.7

—

(3018001) Oat IgE Ab [Units/volume] in Serum

108

1.44

0.64

1.1

1.0

u/ml

0.0

0.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

141

1.38

0.64

1.9

5.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

141

1.38

0.64

1.9

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

103

1137

0.88

0.64

1.3

g/l

1.3

1.5

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

133

1.39

0.64

1.1

1.5

14.0

13.0

0.09

(3013139) Helicobacter pylori Ag [Presence] in Stool

1467

13795

1.03

0.62

1.3

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.62

0.61

6.0

9.1

—

(3015183) Erythrocyte sedimentation rate

826

1.14

0.61

1.2

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.60

0.0

1.4

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.57

0.0

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

112

969

1.12

0.57

5.4

5.3

u/ml

583.6

4338.1

0.49

167

(3022689) Creatine [Moles/volume] in Urine

637

0.85

0.55

1.8

1.4

—

(4094501)

621

5758

1.05

0.55

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

278

2519

1.07

0.54

1.0

1.1

u/ml

0.9

1.0

0.22

120

994

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.42

0.54

1.0

1.1

mmol/l

8.2

8.3

0.11

(1617658) Protocol used for examination of sentinel lymph nodes

179

1594

1.09

0.54

1.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

114

1.36

0.51

3.4

3.2

g/mol

87.1

47.6

0.36

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

114

1.36

0.51

1.0

1.4

0.3

1.8

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.44

0.47

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

134

1.30

0.45

1.0

1.2

nmol/l

16.8

14.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

241

2492

0.94

0.44

1.3

mmol/l

7.7

7.4

0.42

178

1763

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

152

1.28

0.43

1.2

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.41

0.42

1.1

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

254

0.80

0.41

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.41

0.0

1.0

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.41

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

1.47

0.40

1.0

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

0.3

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.39

0.38

2.2

1.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

655

1.11

0.38

1.5

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

908

0.91

0.37

1.1

1.0

u/ml

0.4

1.3

1.28

257

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

113

1.29

0.36

1.0

u/ml

0.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

101

899

1.09

0.36

1.1

u/ml

10.2

6.1

0.68

134

(4212803)

220

1.19

0.34

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.35

0.34

1.0

1.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

114

1.28

0.34

1.0

u/ml

0.0

0.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1410

13968

0.98

0.34

1.4

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

215

0.81

0.34

1.4

1.8

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

248

1.17

0.33

1.0

ug/l

81.8

79.9

0.09

189

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4295

42137

0.99

0.33

3.1

ug/l

0.8

0.38

3015

28637

(3000034) Microalbumin [Mass/volume] in Urine

203

2081

0.95

0.32

3.2

3.0

mg/l

77.0

44.8

1.00

146

1501

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

195

1.19

0.32

1.1

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

561

1.11

0.32

1.7

1.6

ug/l

10.4

9.1

0.93

561

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

1.33

0.31

1.0

1.4

1.2

0.3

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.26

0.29

1.9

1.4

—

(3000285) Sodium [Moles/volume] in Blood

288

1.15

0.29

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

883

0.92

0.28

1.1

1.0

u/ml

1.0

0.8

0.19

198

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

1012

0.93

0.28

1.3

mmol/l

5.7

5.9

1.15

953

(3020650) Glucose [Presence] in Urine

502

1.10

0.27

1.4

—

(46235168) Fasting glucose [Moles/volume] in Blood

226

1.16

0.27

2.3

2.4

mmol/l

8.1

7.3

0.61

106

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

191

1.17

0.26

2.9

2.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

421

1.11

0.25

1.1

1.0

u/ml

0.6

1.4

0.70

216

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

155

1.19

0.25

2.8

2.1

9.7

17.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

338

1.12

0.25

3.3

3.0

ng/l

106.6

123.2

0.12

110

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

175

0.83

0.24

1.1

1.0

—

(3025130) Human papilloma virus identified in Specimen

235

2190

1.04

0.24

1.6

1.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

563

0.91

0.24

1.4

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

349

0.89

0.23

1.1

1.2

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

1.24

0.22

1.0

1.2

—

23.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

136

1255

1.05

0.22

5.4

6.6

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3007733) Chloride [Moles/volume] in Urine

1.18

0.21

1.0

1.1

mmol/l

86.8

81.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

597

5667

1.02

0.21

1.9

1.7

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.20

0.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

123

1.18

0.20

1.5

1.2

—

(3003338) MCHC [Mass/volume]

17710

172272

0.99

0.19

33.5

19.3

g/l

329.9

332.0

170.69

17552

170736

(3027570) Oxalate [Moles/time] in 24 hour Urine

114

1.19

0.19

1.6

1.4

umol/24h

372.6

339.1

0.21

114

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2878

28181

0.99

0.19

10.5

7.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

100

1024

0.95

0.19

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

216

1.12

0.18

2.3

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.19

0.18

1.1

mmol/l

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.19

0.16

1.8

1.5

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

1.14

0.16

5.1

5.6

umol/l

542.3

430.8

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.13

0.16

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

472

1.07

0.15

1.5

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

748

0.95

0.15

1.6

1.5

mmol/l

8.3

8.0

0.30

445

(3051101) Glucose [Moles/volume] in Cord blood

439

0.93

0.15

5.4

5.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

910

1.05

0.14

1.4

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

924

0.96

0.14

1.2

—

(40768800) Prostate Pathology biopsy report

480

4577

1.02

0.14

1.2

—

(4133840)

524

1.06

0.12

1.4

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

653

0.95

0.12

1.7

1.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

173

1632

1.03

0.12

1.0

u/ml

0.2

0.5

0.79

363

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

452

0.94

0.11

1.1

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

197

1868

1.02

0.11

1.1

u/ml

3.6

3.4

0.04

721

(3015076) Soybean IgE Ab [Units/volume] in Serum

775

0.96

0.09

1.1

1.0

u/ml

0.7

1.0

0.17

108

(4038314)

1.12

0.09

1.2

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.02

0.08

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.80

0.08

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.10

0.08

1.3

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.03

0.07

1.0

—

(40758358) Immune stain study

1.12

0.07

1.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

139

0.91

0.07

1.0

u/ml

0.0

0.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.03

0.07

1.1

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2208

21350

1.00

0.06

1.6

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

201

1.06

0.06

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.10

0.05

1.9

1.5

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

108

1.08

0.03

1.0

u/ml

0.0

0.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

300

0.97

0.02

1.1

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

129

1.05

0.01

1.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

110

1.06

0.01

1.2

1.3

u/field

1.0

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

110

1.06

0.01

1.3

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

275

1.02

0.01

1.6

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

130

1.05

0.00

1.2

1.4

—

21331.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

205

1996

1.00

0.00

1.1

u/ml

3.9

3.4

0.15

760

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

165

1.00

0.00

1.6

2.9

pmol/l

4644.4

55.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

200

1.02

0.00

6.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

201

1.01

0.00

3.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

19957

193698

1.00

0.00

6.6

6.0

mmol/mol

40.8

40.2

17.95

18416

177683

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

267

1.02

0.00

1.3

1.1

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.97

0.00

1.4

1.3

1.4

1.3

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.2

—

2.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

0.0

2.3

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.2

—

7.3

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.0

2.5

—

4.0

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_VTE and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_VTE	2.165 [1.99, 2.36]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.076

During the follow-up period (1.1.1998 — 31.12.2019), 32766 out of 80974 females with I9_VTE died.

Males

Parameter	HR [95% CI]	p-value
I9_VTE	2.234 [2.03, 2.46]	< 0.001
Birth year	0.984 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 24507 out of 61597 males with I9_VTE died.

Mortality risk

Mortality risk for people of age

years, who have I9_VTE.

N-year risk	Females	Males
1	0.205%	0.471%
5	1.27%	2.114%
10	2.873%	5.435%
15	5.339%	10.021%
20	9.226%	17.1%

Relationships between endpoints

↥

Index endpoint: I9_VTE – Venous thromboembolism

GWS hits: 64

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Venous thromboembolism

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints